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Abstract: Background: Plants from the Geranium genus, which comprises about 400 species, have been used 
since ancient times in the practice of traditional medicines throughout the world. Therefore, herbal preparations 
based on Geranium species have found wide usage for the treatment of a variety of ailments. The aim of this 
work is to present a review, as comprehensive as possible, of the studies concerning different biological activities 
of Geranium species. 
Methods: Relevant data were obtained through systematic computer searches from major reputed scientific data-
bases, particularly Web of Science and Scopus. Occasionally, information issued in primary sources not covered 
by these databases was also included provided published as peer-reviewed literature. This review covers the lit-
erature disclosed till the end of 2018. 
Results: Accompanying the increasing interest in herbal medicines in general, the evaluation of the biological 
properties of medicinal plants from the Geranium genus has been addressed thoroughly, mostly over the last two 
decades. Geranium species are endowed with a number of different biological activities. Herein, we present a 
survey of the results of the studies concerning these different biological activities. 
Conclusion: Most studies found in the literature effectively contribute to scientifically validate the beneficial 
properties of Geranium plants claimed by traditional medicines and medical herbalism and demonstrate that many 
of them possess evident therapeutic properties. 
Keywords: Geranium species, medicinal plants, biological properties, species, herbalism, ailments. 
1. INTRODUCTION 
 The use of plants as herbal medicines to treat the most varied 
ailments has run parallel to the development of human civilization. 
At the end of the last century, the World Health Organization esti-
mated that about 80% of the world´s population depended on tradi-
tional medicines that largely involved the use of plant extracts or 
their active principles, for their primary healthcare needs [1]. Even 
presently, for millions of people, mainly in developing countries, 
traditional medicines in which herbal medicine is a core part are the 
main source of health care [2]. After a period in which the focus 
was on the use of synthetic drugs, the use and the popularity of 
herbal medicines, as one element of complementary and alternative 
medicines, is increasing worldwide [3, 4]. 
 Although herbal preparations have been used for centuries and 
their properties recognized both by ancient traditional medicines 
and more contemporary herbalism practices, the scientific assess-
ment of such alleged beneficial properties is essential for their cor-
roboration. The main purpose of this work is to present a survey, as 
comprehensive as possible, of the scientific contributions to vali-
date the use of plants from the Geranium genus with specific bio-
logical activities, both in traditional medicine and medical herbal-
ism. Relevant data were obtained through systematic computer 
searches from major reputed scientific databases, particularly “Web 
of Science" and "Scopus”. Occasionally, information issued in 
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primary sources not covered by these databases was also included 
provided published as peer-reviewed literature. Information dis-
closed in primary or secondary sources lacking these two require-
ments was not considered for inclusion in this review. Species that 
were not reported to be used in traditional medicine or herbalism 
practice but whose bioactivity is described based on in vitro or in 
vivo studies were also included in this survey in order to enlarge the 
body of knowledge on the biological activities of Geranium genus. 
This review covers the literature published until the end of 2018. 
The biological activities of G. robertianum were subject to a recent 
review and, therefore, only the information concerning this species 
which was published afterward was included herein [5]. 
 The online database “The Plant List” was used to validate plant 
scientific names [6]. This helped to identify misspellings and the 
use of synonyms for different species. Species were excluded if 
there was confusion or imprecision in the botanical names. When 
an unequivocal validation was not possible, given the difficulty to 
retroactively clarify the correct name of the species studied, it was 
chosen to keep the name given by the authors in their work. Given 
the length of the manuscript, in the name of plants, the species 
authorities were omitted, and the designation of the genus abbrevi-
ated for simplicity.  
2. BOTANICAL DESCRIPTION 
 The Geraniaceae family is composed of about 840 species [6]. 
These plants are annual or perennial herbs or shrubs that are dis-
tributed worldwide, mostly in temperate and subtropical regions [7, 
8]. The species of this family are grouped into seven genera: Cali-
fornia, Erodium, Geranium, Hypseocharis, Monsonia, Pelargonium 
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and Sarcocaulon. The largest genus of this family is Geranium, 
comprising about 400 species [6], distributed throughout the world, 
mainly in temperate climates and in mountain conditions. The ex-
ceptions are only in tropical lowlands, deserts, and Polar Regions 
[9]. The name Geranium, which is derived from the Greek word 
“géranos” that means crane, results from the shape that the fruits of 
the species of this genus acquire resembling a crane beak [10]. 
These species, sometimes woody at the base, are herbaceous, an-
nual, biennial or perennial plants. All have petiolate, palmately 
divided leaves, circular in form, with the divisions toothed or lobed. 
The flowers have five sepals, five equal petals that are often colored 
pink, purplish or bluish-pink, frequently with distinctive veining. 
Both the petioles and the sepals are usually hairy. The style divides 
into five stigmas, which open after the anthers have dehisced, thus 
avoiding self-pollination. The five mericarps, each containing a 
single seed, develop after fertilization of the flower. The method by 
which the seed discharge occurs is utilised to divide the genus Ge-
ranium into the three subgenera (Geranium, Robertium, and 
Erodioideae) [11]. 
3. MEDICINAL USES OF GERANIUM SPECIES 
 Geranium species have been used since ancient times in many 
parts of the world in the practice of different traditional medicine 
systems involving the use of herbal preparations, such as traditional 
Chinese medicine, Indian Ayurveda and various forms of indige-
nous medicine [12]. Accordingly, a relatively large number of 
plants from this genus have been reported for the treatment of a 
wide variety of conditions (Table 1). 
4. BIOLOGICAL ACTIVITY 
 Accompanying the increasing interest in herbal medicines in 
general, the evaluation of the properties of medicinal plants from 
the genus Geranium has been addressed thoroughly, mostly over 
the last two decades. It is now possible to find in the specialized 
literature many studies scrutinizing different biological properties 
of a relatively large group of species from this genus.  
4.1. Anthelmintic Activity 
 Acharya et al. observed that the MeOH extract of G. viscosis-
simum leafs at a concentration of 50 mg/mL in DMSO was capable 
of 100% in vitro egg hatch inhibition of Haemonchus contortus 
(ED50 = 0.63 mg/mL) [93], a gastrointestinal nematode parasite that 
significantly constrains the profitability of livestock production 
systems [94]. 
 A MeOH extract of G. incanum, obtained after sequential ex-
traction of the plant with n-hexane, CH2Cl2 and EtOAc, was found 
to induce ~ 85% larval paralysis of H. contortus within 24 h of 
contact at a concentration of 20 mg/mL [95]. 
4.2. Antibacterial Activity 
 The antibacterial activity of the Geranium genus has been in-
vestigated in some extension. The extracts of about twenty species 
were tested against a large panel of representative Gram-positive 
(Supplementary Table 1) [14, 26, 80, 96-117] and Gram-negative 
bacteria (Supplementary Table 2) [14, 35, 92, 98-105, 108-113, 
115-117], amongst which some important human pathogens, in-
cluding methicillin-resistant Staphylococcus aureus. The studies 
involved mainly alcoholic and aqueous extracts of plants of various 
geographic origins. The disk diffusion test and the broth microdilu-
tion assay were the chief screening methods used to assess the anti-
bacterial properties. The extracts were found to possess a broad 
spectrum of inhibitory activities, and, in the majority of cases, 
minimum inhibitory concentrations (MICs) were determined. 
 Contrary to the solid-liquid extracts, the antibacterial activity of 
essential oils from Geranium species has been much less explored. 
Several essential oils, obtained by hydrodistillation, were assayed 
against Gram-positive (Table 2) and Gram-negative bacteria (Table 
3), including several plant pathogens. The majority of them dis-
played inhibitory activity and MICs were determined for all 
screened positive essential oils. 
4.3. Anticancer Activity 
 The first investigation of the anticancer properties of a speci-
men from Geranium genus seems to have been carried out by Ko-
suge et al. with G. nepalense [41]. In a survey of ninety-one species 
of Chinese herbs with alleged anticancer properties, the MeOH and 
water extracts of G. nepalense were among the few to shown sig-
nificantly in vitro cytotoxic activity against HeLa cervical cancer 
cells. Both extracts, at a concentration of 0.1 mg/mL, exhibited 
growth inhibition greater than 75%. 
 Kashiwada et al. found that an 80% aqueous acetone extract 
from G. thunbergii, possessed significant cytotoxicity against 
RPMI-7951 melanoma tumour cells (ED50 < 20 µg/mL) [123].  
 In a high-throughput screening of nearly nine hundred natural 
product extracts relative to paclitaxel for the antimitotic effect on 
the proliferation of MDA-MB-231 human breast carcinoma cells, 
an EtOH extract of G. maculatum showed to possess moderate 
growth inhibitory activity with an IG50 value of 0.0602 mg/mL 
[124]. Earlier, Mazzio and Soliman found that an EtOH extract of 
G. maculatum also exhibited cytotoxicity (LC50 = 1.170 mg/mL) 
against a Neuro 2-a murine neuroblastoma cell line [125]. 
 Kim tested a 70% aqueous EtOH extract of G. krameri against a 
B16F10 murine melanoma cell line but observed relatively low 
cytotoxicity, with an ID50 value of 469.26 µg/mL [126]. 
 Various aqueous (decoction and infusion) and organic extracts 
(n-hexane, CH2Cl2, EtOAc, acetone, and MeOH, obtained by suc-
cessive extraction) from G. robertianum were tested against several 
human cancer cell lines: breast (MCF-7), non-small cell lung (NCI-
H460), cervical (HeLa) and hepatocellular (HepG2) carcinomas 
[127]. All extracts revealed to possess cytotoxic activity, with GI50 
values ranging from 45.68 to 236 µg/mL. Unlike the other extracts, 
for which the grown inhibition activity was very diverse amongst 
the different cell lines, the acetone extract was consistently the most 
cytotoxic for all the assayed cell cultures (GI50 from 57 to 60 
µg/mL). Ellipticine, a potent antineoplastic agent, was used as a 
positive control, displaying GI50 values from 0.91 to 2.29 µg/mL. 
 An identical study by the same authors with G. molle against 
the same cell lines provided similar results with the acetone extract 
being the most cytotoxic one, exhibiting GI50 values from 50 to 85 
µg/mL [128]. 
 The bio-guided fractionation of some of the more active ex-
tracts of both G. robertianum and G. molle resulted in several frac-
tions with improved cytotoxicity in comparison with the corre-
sponding crude extracts [129, 130]. 
 Şöhretoğlu et al. assessed the cytotoxic activity of different 
extracts of G. psilostemon and G. tuberosum, two plants widely 
used in traditional Turkish medicine, against a KB human epider-
moid carcinoma cell line [131]. The extracts, resulting from initial 
extraction of the plants with 80% aqueous MeOH, followed by 
dissolution of the crude extracts in water and partition of the water-
soluble fraction against petroleum ether, EtOAc and n-BuOH, 
showed dose-dependent cytotoxicity in the range of the concentra-
tions tested (10 µg/mL - 0,1 µg/mL), being negligible below 10 
µg/mL. At this concentration, both aqueous extracts of G. psiloste-
mon and G. tuberosum exhibited a proliferative inhibition of ~ 65% 
and ~ 55%, respectively, comparable to that of doxorubicin, an 
antibiotic largely used in cancer chemotherapy, used as a positive 
control. The n-BuOH and EtOAc extracts showed cellular prolifera-
tion inhibition lower than 30% at the same concentration.  
 The anti-proliferative activity of 80% aqueous EtOH and EtOH 
extracts of G. purpureum was assessed against Hep G2 human he-
patocellular carcinoma cells and compared with that displayed 
against a normal skin fibroblasts CRL-2522 cell line [108]. The 
1840    Current Pharmaceutical Design, 2020, Vol. 26, No. 16 Graça et al. 
Table 1. Traditional uses of Geranium species. 
Geranium Species Country Use References 
G. aculeolatum Burundi Ringworm, purulent rashes, diarrhoea [13]  
G. asphodeloides  Turkey Wounds [14]  
G. ayavacense  Peru Hypoglycaemic, astringent, ulcerative stomatitis, gastritis, gingivitis, gastric lesions [15]  
G. bellum  Mexico Fever, pain, gastrointestinal disorders [16]  
G. canescens  Africa  Diarrhoea  [17]  
G. carolinianum  China Diarrhoea, rheumatic arthritis [18] 
G. berteroanum  Argentine  Hepatic and intestinal disorders, stomach problems [19, 20] 
G. core-core  Chile Cataracts, shock, fever, astringent, toothache, inflammatory conditions [21]  
G. dissectum  Lebanon Rheumatism [22]  
G. himalayense  India Stomach ache [23]  
G. ibericum  Turkey Wound healing [24]  
G. incanum  South Africa  Diarrhoea, menstruation [17, 25]  
G. koreanum  China Itching, bruising, enteritis, chronic diarrhoea, liver disorders [26]  
G. lucidum India Diuretic, astringent [23]  
- Spain Wounds, cuts [27]  
G. macrorrhizum  Bulgaria, Poland, Romania Antiviral, styptic in menorrhagia and haematuria, diarrhoea, dysentery, gastrointestinal ulcers  [12]  
- Bulgaria Spasmolytic, cardiotonic, aphrodisiac, hypotensive agent, central depressive [28, 29] 
- Serbia Astringent, inflammation of gastric mucous membranes [28] 
- Montenegro Inflammation of the skin and mucous membranes [30] 
- Bosnia and Herzegovina  Stomach disorders [31] 
G. maculatum  North America, Europe Diarrhoea, dysentery, gastrointestinal ulcers, styptic in menorrhagia and haematuria, haemorrhoids, 
wounds, sores, bleeding 
[12] 
- Canada Duodenal ulcers, diarrhoea, haemorrhoids [32] 
G. mascatense  Pakistan Diuretic, gastrointestinal disorders, diarrhoea, ulcers [33] 
- India Antiseptic, diuretic, astringent, liver disorders, fever [23] 
- Nepal Amoebic dysentery [34] 
G. maximowiczii  China Rheumatism [32] 
G. mexicanum  Mexico, Venezuela Laxative in infants, antispasmodic, rashes, wounds [12] 
- Mexico Diarrhoea, dysentery, stomach ache, purgative, tonsillitis, cough, whooping cough, urticarial, pruritus [35-37] 
G. molle Portugal Antiseptic, stomach ache, gingivitis, eye inflammation, uterus inflammation, cancer  [38] 
- India Analgesic, astringent, wounds [23] 
G. nepalense India Antibacterial, diuretic, astringent, renal disorders, fever, toothache, ulcers, wounds, stomach disorders, 
jaundice, itching, eczema, diarrhoea, endometriosis 
[12, 23, 39, 
40]  
- China Cancer, stomach ache, eyes problems, nose inflammation  [41, 42] 
- Pakistan Renal infections, diarrhoea, cholera [43, 44] 
- Nepal Diarrhoea, endometriosis, shore throat, renal problems [12, 45] 
G. niveum  Mexico Analgesic, purgative, infectious diarrhoea, gastrointestinal disorders, fever, kidney pain, urological 
problems, diabetes, skin tumours, dermatological conditions 
[46-49] 
G. phaeum  Bulgaria, Serbia Astringent, inflammation of gastric mucous membranes, aphrodisiac [28]  
 
(Table 1) Contd.... 
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Geranium Species Country Use References 
G. platyanthum  Japan, China Rheumatism, numbness of limbs, pain [12]  
- Korea Enteritis, dysentery, diarrhoea [50]  
G. polyanthes  India Ulcers, headache [40]  
G. pratense  China, Japan, Europe Acute bacillary dysentery [12]  
- Great Britain Antihemorragic, astringent [51]  
- India Analgesic, pneumonia, swelling, liver and gastric disorders, cold, cough, fever, wounds, bruises [23, 52-54]  
G. purpureum  Portugal Antiulcerative, analgesic, vulnerary, cancer, intestinal antispasmodic, gastric and hepatic protective, 
gastritis, sea-sickness, gall-bladder ailments, influenza, intestinal anti-inflammatory, renal antispas-
modic, inflammations 
[55, 56] 
G. pusillum  India Analgesic, astringent, wounds [23] 
G. rivulare  India Insect bites, ulcers [12] 
G. robertianum  Europe, USA, China, Japan, 
North Africa, India, South 
America 
Diarrhoea, haemorrhage, jaundice, dispersal of kidney and gall stones, mouthwash, burns, wounds [12] 
- Montenegro Diarrhoea, gastritis, inflammatory conditions of gallbladder, kidney and bladder, poorly healing 
wounds, rashes, sinuses diseases 
[30] 
- Italy Parasitosis of the scalp, mosquito repellent, mosquito bites, astringent, ovine, cattle and horses scabs, 
mouth and throat inflammations 
[57-60] 
- Spain Antipneumonic, antiecchymotic, antiherpetic, vulnerary, sore throat, cancer, lipomas, diarrhoea in 
animals 
[61-63] 
- Israel Cholesterol [64]  
- Portugal Diabetes, blood depurative, tumours, stomach ulcers, open sores [65, 66] 
- Bosnia and Herzegovina Male fertility improvement [31] 
- Serbia Intestinal ailments in animals [67] 
- Mexico Eyes, venereal diseases, mouth disorders, gastrointestinal disorders, cutaneous or connective tissue 
disorders 
[68] 
- Morocco Hypoglycaemic, tonic, antispasmodic, cancer [69]  
- Africa  Diarrhoea  [17]  
- India Astringent, haemostatic, tumours, ulcers, jaundice, fever, renal disorders [23]  
G. rotundifolium  India Astringent, diuretic [23]  
- Iran Cold [70]  
- Pakistan Stomach ache, jaundice [71]  
- Italy Vulnerary, stomatitis, gastrointestinal complaints in cattle [72]  
G. ruizii Peru Diabetes, inflammation, chronic diarrhoea [73]  
G. sanguineum  Eastern Europe Haemorrhage, diarrhoea [12]  
- Bulgaria Hypotensive, antivirus, immune-stimulant, sedative, CNS depressive, pruritus, itches, skin lesions, 
eruptive skin 
[74, 75] 
- Italy Stomatitis, astrigent [74]  
G. schiedeanum  Mexico Fever, pain, gastrointestinal disorders [76]  
G. seemannii  Mexico, Caribbean, Central 
America 
Diuretic, laxative, obesity [77]  
G. sessiliflorum  Peru Uterine cancer, liver and kidney inflammation [78]  
G. sibiricum  India Diuretic, astringent, wounds [23]  
(Table 1) Contd.... 
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Geranium Species Country Use References 
- Korea Diarrhoea, intestinal inflammation, dermatitis, cancer [79]  
G. strictipes  China Enteritis, diarrhoea, chronic gastritis [80]  
G. thunbergii  China, Japan Inflammation of gastrointestinal system, diarrhoea, haematological and liver disorders [23]  
!" Japan Diarrhoea, liver disorders, chronic gastroenterophaty, stomach ache [81, 82]  
G tuberaria  India Urinary disorders [83]  
G. tuberosum  Cyprus Cardiovascular, skin [84]  
- Lebanon Haemorrhoids, diuresis, diabetes, male sterility [85]  
G. wallichianum  India Astringent, toothache, otorrhoea, ophthalmia, dysentery, diarrhoea, cough and cold, headache, wounds, 
leucorrhoea, backache, rheumatic pain, fever, cough, jaundice, body pain, styptic 
[23, 86-88] 
!" Pakistan Hypotensive, uterine diseases, stomach disorders, tonic, gastric ulcers, jaundice, toothache, joint pains, 
diarrhoea, cholera, hepatitis, liver problems, kidney problems, chronic dysentery, leucorrhoea 
[43, 44, 89, 
90]  
!" Nepal Cough, cold, join pains, menstruation problems [91]  
G. wilfordii  China Chronic rheumatism, gastrointestinal disorders, diarrhoea, dysentery [12, 92]  
 
Table 2. MIC (mg/mL) values of Geranium species essential oils against Gram-positive bacteria. 

















































































































































































































































































G. asphodeloides aerial parts - 0.3551 - - - - - - - 0.3552 - - - - - - - [118]  
G. columbinum aerial parts - - 14.03 - 0.4374 3.505 - - 7.006 - 7.007 3.504 1.7503 - - - - [119]  
- underground parts - - 12.03 - 6.004 12.05 - - 6.006 - - 6.004 12.03 - - - - - 
G. lucidum whole plant - - 13.43 - 1.6754 6.705 - - 13.46 - 13.47 1.6754 3.353 - - - - - 
G. macrorrhizum aerial parts - - 0.001 - - 0.625 - - - - - 0.312 0.039 - - - - [120]  
- rhizomes - - 0.0004 - - 2.5 - - - - - 0.625 2.5 - - - - - 
G. psilostemon aerial parts - 4.2201 - - - - - - - 4.2202 - - - - - - - [118]  
G. purpureum aerial parts - 3.3651 - - - - - - - 3.3652 - - - - - - - [118]  
G. pyrenaicum aerial parts - 0.1671 - - - - - - - 0.3352 - - 0.3358 - - - - [118]  
G. robertianum leaves 59 - - 59 - - - - - - - -  1.259 2.59 59 2.59 [121]  
- aerial parts - 0.8051 - - - - - - - 0.8052 - - 0.8058 - - - - [118]  
G. sanguineum whole plant  - - 2.5010 - - 2.5011 - - 0.31212 - 5.0010 5.0012 5.0012 - - - - [122]  
- aerial parts - 3.7751 - - - - - - - 1.8872 - - - - - - - [118]  
MIC - Minimum inhibitory concentration. - - No activity within the tested concentration range.  
1 Ampicillin (MIC = 15 µg/mL) was used as a reference compound. 2 Streptomycin (MIC = 4 µg/mL) was used as reference compound. 3 Chloramphenicol (MIC = 0.015 mg/mL) was 
used as reference compound. 4 Chloramphenicol (MIC = 0.062 mg/mL) was used as a reference compound. 5 Chloramphenicol (MIC = 0.250 mg/mL) was used as reference com-
pound. 6 Chloramphenicol (MIC = 0.031 mg/mL) was used as reference compound. 7 Chloramphenicol (MIC = 0.125 mg/mL) was used as a reference compound. 8 Ampicillin (MIC 
= 35 µg/mL) was used as reference compound. 9 Tetracycline (MIC = 30 µg/mL) was used as a reference compound. 10 Tetracycline (MIC = 0.195 µg/mL) was used as a reference 
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Table 3. MIC (mg/mL) values of Geranium species essential oils against Gram-negative bacteria. 






























































































































































































































































































G. asphodeloides Aerial parts - - - - - - - - - - - - - - - - - [118]  
G. columbinum Aerial parts 0.8751 - - - - 14.02 1.7502 14.02 - - - - 7.003 0.8754 - 14.003 - [119]  
- Underground parts 12.01 - - - - - 0.7502 - - - - - 12.03 6.004 - - - - 
G. lucidum Whole plant - - - - - 13.42 0.8732 13.42 - - - - 13.43 0.8374 - 13.43 - - 
G. macrorrhizum Aerial parts 2.5 - 0.312 - - - 0.625 - - - - - - - - - - [120]  
- Rhizomes 5 - 2.5 - - - 1.25 - - - - - - - - - - - 
G. psilostemon Aerial parts - - - - - - - - - - - - - - - - - [118]  
G. purpureum Aerial parts - - - - - - - - - - - - - - - - - [118]  
G. pyrenaicuum Aerial parts - - - - - - - - - - - - - - - - - [118]  
G. robertianum Leaves - - - - 105 - - - 105 105 105 105 - - - - - [121]  
- Aerial parts - - - - - - - - - - - - - - - - - [118]  
G. sanguineum Whole plant  0.3126 1.257 5.008 - - 5.008 2.507 - - - - - 2.507 - - 5.006 - [122]  
- Aerial parts - - - - - - - - - - - - - - - - - [118]  
MIC - Minimum inhibitory concentration. - - No activity within the tested concentration range. 
1 Chloramphenicol (MIC = 0.031 mg/mL) was used as a reference compound. 2 Chloramphenicol (MIC = 0.062 mg/mL) was used as a reference compound. 3 Chloramphenicol 
(MIC = 0.125 mg/mL) was used as a reference compound. 4 Chloramphenicol (MIC = 0.250 mg/mL) was used as a reference compound. 5 Tetracycline (MIC = 30 µg/mL) was used 
as reference compound. 6 Tetracycline (MIC = 0.195 µg/mL) was used as a reference compound. 7 Tetracycline (MIC = 0.390 µg/mL) was used as a reference compound. 8 Tetracy-
cline (MIC = 1.562 µg/mL) was used as reference compound. 
 
growth inhibition was found to be dose-dependent, but not signifi-
cantly different in the two cell lines for each tested concentration. 
 G. macrorrhizum has been one of the most studied Geranium 
species concerning anticancer activity. Venskutonis et al. obtained 
an alcoholic extract of the plant by partition, between water and n-
BuOH, of a 96% aqueous EtOH extract of the residue resulting 
from the initial extraction of the plant material with tert-butyl 
methyl ether, and found it to be cytotoxic in vitro against bovine 
leukemia virus-transformed lamb embryo kidney fibroblasts (line 
FLK) (LC50 = 112 µg/mL) [132]. Extraction of the residue remain-
ing after extraction with 96% aqueous EtOH with water, yielded, 
after partition against n-BuOH, an aqueous fraction with even 
greater inhibitory activity (LC50 = 63 µg/mL). The prooxidant na-
ture of the cytotoxicity displayed by the extract was evidenced 
since it was prevented by the antioxidant N,N'-diphenyl-p-
phenylenediamine (DPPD) and was enhanced by N,N’-bis (2-
chloroethyl)-N-nitrosourea (BCNU) which acts as a prooxidant. 
The G. macrorrhizum extract did not reveal genotoxicity in vivo in 
Drosophila melanogaster, although it showed to be genotoxic in 
cytogenetic tests in vitro. Sharopov et al. demonstrated that a 
MeOH extract of the leaves and roots of G. macrorrhizum exhibited 
moderate cytotoxic activity against human leukaemia CCRF-CEM 
and CEM/ADR 5000 cell lines, with IC50 values of 22.4 and 112.3 
µg/mL, for the first cell line, and 98.3 and 154.2 µg/mL, for the 
second one, respectively [133]. As a comparison, the IC50 values 
determined for doxorubicin were, respectively, 2.3 µg/mL for the 
CCRF-CEM cells and 5.2 µg/mL for the CEM/ADR cells. A sub-
critical water extract from G. macrorrhizum leaves was also found 
to be cytotoxic in vitro for human cervix carcinoma - HeLa deriva-
tive (Hep2c), human rhabdomyosarcoma (RD) and murine fibro-
blast (L2OB) cells, with IC50 values ranging from 12.22 to 28.38 
µg/mL [105]. Cisplatin, a standard chemotherapeutic agent effec-
tive for a great number of cancers, was used as a positive control 
with IC50 values from 0.72 to 1.4 µg/mL. 
 Recently, Herrera-Calderon et al. assessed the cytotoxicity of a 
96% aqueous EtOH extract of G. ruizii against a relatively large 
number of human cancer cell lines: MCF-7 (breast), H-460 (non-
small cell lung), HT-29 (colon), M-14 (melanoma), K-562 (myelo-
genous leukaemia) and DU-145 (prostate) [134]. The extract exhib-
ited IC50 values from 75.13 to 196.54 µg/mL, showing relatively 
low toxicity in comparison to 5-fluorouracil, a well-known antican-
cer drug used as control (IC50 values from 0.33 to 4.08 µg/mL, ex-
cept for the DU-145 cell line for which IC50 > 15.63 µg/mL). 
4.4. Antidiarrhoeal Activity 
 Various Geranium species are used internally for the treatment 
of diarrhoeal conditions [12] but, conversely, the number of species 
that have been studied is relatively small. One of the mechanisms in 
diarrhea pathogenesis is secretory diarrhoea, which occurs when the 
secretion of water into the intestinal lumen exceeds absorption, a 
process that may easily lead to marked dehydration [135]. Extracts 
of the aerial parts of G. mexicanum were found to display antisecre-
tory activity in Sprague-Dawley rats [136]. The aqueous extract of 
the plant showed 42.1% inhibition, comparable to that of lopera-
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mide (43.3%), a standard drug for the treatment of a number of 
types of diarrhea. On the other hand, the MeOH extract showed 
much better antisecretory action than the antidiarrheal drug, dis-
playing as much as 93.4% inhibition. Both the aqueous and the 
MeOH extract of the roots were devoid of antisecretory properties. 
 Alterations in intestinal motility usually increased propulsion, 
are observed in many types of diarrhea [135]. MeOH extracts of the 
roots of G. mexicanum showed 100% of inhibition of charcoal-gum 
acacia-induced hyperperistalsis in Sprague-Dawley rats (loperamide 
exhibited 34% inhibition at a dose of 10mg/Kg) [137]. Moreover, in 
what concerns antipropulsive properties, the MeOH extract of the 
aerial parts of the plant turned out to be inactive. 
 Amabeoku showed that the aqueous extract of the leaves of G. 
incanum possessed antidiarrhoeal and antipropulsive activities in 
castor oil-induced diarrhoea in albino mice, reducing the faecal 
output, the number of diarrhoeal episodes and the intestinal propul-
sion of charcoal meal, with a net effect similar to that of loperamide 
[17]. 
 An aqueous extract of G. ocellatum leaves exhibited marked 
anti-diarrhoeal effect in castor oil-induced diarrhoea in Wistar rats, 
reducing the total number and the weight of wet faeces signifi-
cantly. The inhibition of diarrhoea rats treated with the extract was 
78.87%, comparable to that of loperamide (79.51%) [138]. 
4.5. Antifungal Activity 
 The antifungal properties of several species from the Geranium 
genus have also gained much attention. Solid-liquid extracts, 
mostly alcoholic and water extracts, of about a dozen species, were 
assayed against a panel of plant and human pathogenic fungi, in-
cluding the most commonly found species in opportunistic mycoses 
such as Aspergillus and Candida (Supplementary Table 3) [14, 98-
106, 110, 111, 113, 114, 117, 139]. Almost all extracts were found 
to have antifungal activity. 
 The antifungal activity of essential oils from various Geranium 
species was also tested against several different fungi (Table 4). 
The majority of them displayed inhibitory activity. 
4.6. Antiglycation Activity 
 Non-enzymatic protein glycosylation (glycation) and the forma-
tion of advanced glycation end products (AGEs) contribute to the 
development or worsening of many degenerative diseases and aging 
of organisms [143]. In a survey of several Pakistani traditional me-
dicinal plants to combat diabetes, Zia-ur-rehman et al. found that a 
95% aqueous MeOH extract of G. collinum was capable of signifi-
cant inhibition (~ 62%) of the formation of AGEs when compared 
with the positive control (quercetin-3-O-rutinoside, 86% inhibition) 
[144]. A similar extract of G. wallichianum did not inhibit AGE 
formation significantly (~ 3%).  
4.7. Antihepatotoxic Activity 
 Radulović et al. reported a significant dose-dependent antihepa-
totoxic action of the MeOH extracts of the leaves and rhizomes of 
G. macrorrhizum in CCl4-induced hepatotoxicity in Wistar rats, 
decreasing the levels of the enzymes aspartate transaminase (AST), 
alanine transaminase (ALT), alkaline phosphatase (ALP), γ-
glutamyl transpeptidase (γ-GT), pseudocholinesterase (PCHE) and 
total bilirubin, and reducing the extent of morphological malforma-
tions of the liver [104].  
 The pre-treatment of Wistar rats with 70% aqueous acetone 
extracts of the aerial parts of G. schiedeanum showed to decrease 
and delay thioacetamide-induced liver injury, lowering the levels of 
AST and ALT [76]. This G. schiedeanum extract also exhibited a 
hepatoprotective effect on the damage caused by ethanol on partial 
post-hepatectomy liver regeneration in Wistar rats [145]. Vargas-
Mendoza et al. observed that the pre-treatment of Wistar rats with 
the 70% aqueous acetone extract from G. schiedeanum stimulated 
Table 4. Antifungal activity of Geranium species essential oils.§ 






































































































































































G. asphodeloides Aerial parts - - - - - - - - - - - - - [118]  
G. columbinum Aerial parts - 0.1091 - 7.002 0.4373 - - - 7.001 - 0.4374 - - [119]  
- Underground parts - 0.3751 - 12.02 1.753 - - - 12.01 - - - - - 
G. lucidum Whole plant - 0.8371 - 13.42 0.8373 - - - - - 6.704 - - [119]  
G. macrorrhizum Aerial parts - 5 - 10 - - - - 10 - - - - [120]  
- Rhizomes - 5 - 10 - - - - 10 - - - - - 
- Whole plant9 - - - - - - - - - - - - - [140]  
G. psilostemon Aerial parts - - - - - 4.2205 - - - - - - - [118]  
G. purpureum Aerial parts - - - - - - - - - - - - - [118]  
G. pyrenaicum Aerial parts - - - - - 0.3355 - - - - - - - [118]  
G. robertianum Aerial parts - - - - - - - - - - - - - [118]  
G. sanguineum Whole plant  - 0.3121 - - 5.006 - - - 10.07 - 2.508 - - [122]  
- Aerial parts - - - - - 3.7755 - - - - - 37755 - [118]  
G. viscosissimum Whole plant9 + - - - - - - - - - - - - [141]  
- Whole plant9 - - - - - - + + - + - - + [142]  
§ Numeric values correspond to MIC (minimum inhibitory concentration) (mg/mL). # Mattress dust isolate. * Strain not identified. + - With activity. - - No activity within the tested 
concentration range. 
1 Nystatine (MIC = 0.039 µg/mL) was used as a reference compound. 2 Nystatine (MIC = 0.078 µg/mL) was used as a reference compound. 3 Nystatine (MIC = 2.50 µg/mL) was 
used as a reference compound. 4 Nystatine (MIC = 1.75 µg/mL) was used as a reference compound. 5 Fluconazole (MIC < 8 µg/mL) was used as reference compound. 6 Nystatine 
(MIC = 6.250 µg/mL) was used as reference compound. 7 Nystatine (MIC = 0.390 µg/mL) was used as a reference compound. 8 Nystatine (MIC = 12.50 µg/mL) was used as a refer-
ence compound. 9 Presumably. 
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the endogenous antioxidant defense system, increasing the levels of 
catalase (Cat), superoxide dismutase (SOD), glutathione peroxidase 
(GPx) and glutathione reductase (GR) in the liver of the rats, after 
intoxication with a sublethal dose of thioacetamide [146]. 
 In a study aimed at scrutinizing the protective effect and related 
molecular mechanism of a MeOH extract of G. koreanum on 
NaAsO2-induced cytotoxicity in HepG2 human liver cancer cells 
and liver damage in ICR mice, Akanda et al. found that co-
treatment with the extract attenuated induced hepatotoxicity both in 
vivo and in vitro [147]. On HepG2 cells the G. koreanum extract 
significantly mitigates cell viability loss and the raise of reactive 
oxygen species (ROS) and lactate dehydrogenase (LDH) levels. In 
vivo, co-treatment with the extract resulted in a remarkable im-
provement of the histopathological changes caused by NaAsO2, as 
well as of the liver function by reducing ALT and AST to nearly 
normal levels. Additionally, the study showed that the hepatopro-
tective activity was probably involved in the modulation of the 
mitogen-activated protein kinases (MAPK)(ERK1/2, JNK, 
p38)/caspase-3 signalling pathways. 
4.8. Antihyperglycaemic Activity 
 Rodriguez et al. evaluated the hypoglycaemic activity of a 70% 
aqueous EtOH extract of G. core-core in normoglycaemic and al-
loxan-induced diabetic rats [21]. The results showed that a single 
oral dose of 500 mg/Kg, as well as the chronic administration of 
250 mg/Kg (7 days), significantly reduced blood glucose levels 
both of normoglycaemic and alloxan-diabetic rats under glucose 
tolerance test conditions. 
 A 96% aqueous EtOH extract of G. ruizii showed the anti-
hyperglycaemic effect on rats with experimental diabetes induced 
by alloxan at a dosage of 150 mg/Kg [148]. Moreover, it was found 
that the extract had a protective effect in the pancreas. 
 An aqueous extract of G. ayavacence also revealed to signifi-
cantly decrease glycaemia in alloxan-induced diabetic rats at dos-
ages of 300 and 500 mg/Kg, in a sustained way over a 24 h post-
administration period [15]. 
 Karato et al. observed that a MeOH extract of G. dielsianum 
was able to suppress blood glucose elevation after oral administra-
tion of sucrose, maltose and starch, but not of glucose, in hypergly-
caemic (ddY) model mice, suggesting that the extract had no effect 
on glucose absorption but probably inhibited the carbohydrate-
hydrolyzing enzymes involved in the metabolism of disaccharides 
[149]. The in vitro investigation of the effect of the extract on the 
activity of α-glucosidase from mouse small intestine showed that 
the enzyme, which breaks down starch and disaccharides to glu-
cose, was inhibited in a dose-dependent manner, strongly indicating 
that the extract has an anti-hyperglycaemic effect by inhibiting α-
glucosidase activity. 
 Curiously, the EtOAc soluble fraction of a 95% aqueous EtOH 
extract of G. thunbergii was found to exhibit considerable inhibi-
tory activity against yeast α-glucosidase but only very weak inhibi-
tory activity against mammalian α-glucosidase from rat intestinal 
acetone powder [150]. Yeast α-glucosidase is extensively used as a 
screening material for α-glucosidase inhibitors, but it is known that 
the results not always agree with those obtained with the enzyme 
from mammal origin [151]. 
 Numonov et al. assessed the antihyperglycaemic activity of 
several aqueous and aqueous-EtOH extracts of the roots of G. 
collinum and found that they possessed promising inhibitory activi-
ties against yeast α-glucosidase, with IC50 values ranging from 0.07 
to 1.98 µg/mL [152]. The 50% aqueous EtOH extract exhibited 
potent inhibitory activity, with an IC50 value of 0.07 µg/mL, con-
siderably superior to that of acarbose (IC50 = 2.19 µg/mL), a α-
glucosidase inhibitor commonly used as an antidiabetic agent. This 
extract also revealed potent inhibitory activity against the protein 
tyrosine phosphatase (PTB-1B), a key negative regulator of the 
insulin signaling pathway and a well-known target of type 2 diabe-
tes whose inhibition is anticipated to preserve glucose homeostasis 
[153]. The observed IC50 value (0.10 µg/mL) was about 15 times 
lower than that of 3-(3,5-dibromo-4-hydroxybenzoyl)-2-ethyl-N-[4-
(1,3-thiazol-2-ylsulfamoyl)phenyl]-1-benzofuran-6-sulfonamide 
(IC50 = 1.46 µg/mL), the positive control used and an established 
PTP-1B inhibitor. 
 Recently, an 80% aqueous MeOH extract from G. asphodeloi-
des and several sub-extracts obtained by partition of the crude 
MeOH extract between water and, successively, n-hexane, EtOAc 
and n-butanol were shown to exhibit very potent inhibitory activity 
against yeast α-glucosidase (IC50 values from 0.85 to 11.65 µg/mL) 
compared with acarbose (IC50 = 40.47 µg/mL) [154]. The EtOAc 
sub-extract displayed the highest inhibitory effect with an IC50 
value of 0.85 µg/mL. 
4.9. Antihypertensive Activity 
 In a pharmacological study of several extracts of G. macrorrhi-
zum, Petkov showed that some of them possessed an evident hy-
potensive action on anesthetized cats (acute experiments) and 
wakeful dogs (chronic experiments) with induced hypertension 
[155]. The EtOH extract of the whole plant and a MeOH fraction 
from the rhizome displayed strong and prolonged hypotensive ef-
fects. Several fractions from the total MeOH extract of the aerial 
parts of the plant also showed significant hypotensive action. The 
hypotensive activity was found to result mainly from a direct effect 
on the vascular smooth muscles. 
 The 70% aqueous EtOH extract of G. pratense was found to 
possess remarkable in vitro inhibitory activity against angiotensin I-
converting enzyme (ACE I) (IC50 = 81 µg/mL), an enzyme of the 
renin-angiotensin system which plays a central role in the regula-
tion of blood pressure [156]. 
 Earlier, Hansen et al. verified that the aqueous extract of G. 
core-core was able to inhibit ACE activity by 33% [157]. 
4.10. Anti-inflammatory Activity 
 Küpeli et al. evaluated the anti-inflammatory activity of an 
aqueous fraction of G. finitimum, obtained by partition of a crude 
MeOH extract between water and CHCl3, using three acute in-
flammation models in Swiss albino mice: carrageenan- and prosta-
glandin E2 (PGE2)-induced paw oedema and 12-O-tetradecanoyl-
phorbol-13-acetate (TPA)-induced ear oedema [32]. In comparison 
with the anti-inflammatory drug indomethacin (at 10 mg/Kg), the 
extract, at a dosage of 100 mg/Kg, significantly inhibited both car-
rageenan- (26.6%, 3 hours post injection; 38% for indomethacin) 
and PGE2-induced paw oedema (25.3%, 24 minutes post-injection; 
13% for indomethacin), as well as the weight of TPA-induced ear 
oedema (42.4% after 4 hours of topical application, 59.7% for in-
domethacin). 
 A 50% aqueous EtOH extract of G. wilfordii, at a dose of 1.69 
g/kg administered intragastrically for 5 days to Sprague-Dawley 
rats, significantly inhibited swelling in the carrageenan-induced 
paw oedema 1 hour post carrageenan injection, an effect considera-
bly stronger than that of acetylsalicylic acid (0.1 mg/kg) used as 
positive control [158]. The pre-treatment of ICR mice with the 
same extract administered intragastrically (1.69 g/kg for 5 days) 
suppressed xylene-induce ear oedema by 33.3%, while acetylsali-
cylic acid (0.1 mg/kg) showed 35.6% reduction in swelling. The 
same authors demonstrated in vitro, using L929 murine fibrosar-
coma cells, that the extract displayed activity against the expression 
of tumor necrosis factor-alpha (TNF-α), a key cell signalling pro-
tein in most inflammatory responses, in a dose-dependent manner, 
the inhibitory effect reaching 93.32% at a nontoxic dosage of 128 
ug/mL. 
 Choi et al. examined the anti-inflammatory activity of a 50% 
aqueous EtOH extract of G. thunbergii in bone marrow-derived 
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macrophages (BMDM) activated by interferon-γ (INF-γ) and bacte-
rial lipopolysaccharides (LPS) and found that the extract exerted a 
significant inhibitory effect on induced inflammation at non-toxic 
doses [159]. The anti-inflammatory effect seemed to be associated 
with the activation of the nuclear erythroid 2-related factor (Nrf2), a 
key transcription factor in anti-inflammatory systems. An EtOAc 
fraction of a 95% aqueous MeOH extract of G. thunbergii, obtained 
by the sequential partition of the later between water and various 
organic solvents, also showed anti-inflammatory effect on LPS-
stimulated RAW 264.7 cells [160]. The fraction effectively sup-
pressed NO production, in a dose-dependent way (> 60% inhibition 
at a concentration of 50 µg/mL), by down regulating inducible ni-
tric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expres-
sion. Sung et al. investigated the effect of hot water extracts of G. 
thunbergii obtained with different extraction times on the expres-
sion of iNOS, COX-2, interleukin 1 β (IL-1β) and interleukin 6 (IL-
6) in LPS-stimulated RAW 264.7 cells [161]. At 10 µg/mL, the 
most active extract, obtained by extracting the plant material at 90 
ºC for 2 h, decreased the expression of those inflammatory media-
tors between 66 and 79%. 
 The oral administration of a 70% aqueous acetone extract of G. 
bellum to Wistar rats significantly suppressed the oedematous re-
sponse to carrageenan-induced paw oedema, in a dose-dependent 
manner [162]. The observed oedema inhibition rates were 41.1 and 
70.5%, at extract dosages of 150 and 300 mg/kg, respectively, after 
6 hours of carrageenan injection. The commonly used nonsteroidal 
anti-inflammatory drugs indomethacin and diclofenac (at 30 
mg/Kg) produced oedema inhibition rates of 42.8 and 47.2%, re-
spectively, after the same post administration period. 
 A 99% aqueous EtOH extract of G. sibiricum was found to 
exhibit interesting anti-inflammatory activity in phorbol-12-
myristate 13-acetate plus calcium inophore A23187 (PMACI) 
stimulated human mast cells (HMC-1) through modulation of pro-
inflammatory cytokine interleukin-1β expression and NO produc-
tion [79]. 
 An EtOAc fraction of an aqueous extract of G. nepalense 
showed significant anti-inflammatory activity on TPA-induced ear 
oedema in Kumming mice at 2.5 g/Kg, similar to that of aspirin (0.6 
g/kg) used as a positive control [163]. 
 Piwowarski et al. demonstrated the anti-inflammatory action of 
an aqueous extract of G. pratense on human THP-1 cell line-
derived macrophages [164]. It was shown that the plant’s extract 
was a source of bioavailable gut microbiota metabolites, i.e. uro-
lithins, which had an inhibitory action on the pro-inflammatory 
functions of the INF-γ and LPS stimulate macrophages. 
 Li et al. showed that an aqueous extract of G. carolinianum 
possessed anti-inflammatory properties in vivo, suppressing fresh 
egg white-induced acute paw oedema in Sprague-Dawley rats and 
dimethylbenzene-induced ear oedema in ICR mice, in a dose-
dependent way [165]. The G. carolinianum extract orally pre-
medicated at a dose of 500 mg/Kg displayed an anti-inflammatory 
effect even superior to that of indomethacin (5 mg/Kg) used as a 
positive control in the fresh egg white induced paw oedema test. At 
doses of 250 and 500 mg/Kg the extract also revealed significant 
inhibitory activity against acute inflammation induced by dimethyl-
benzene when compare to dexamethasone used as control. 
 A water extract of G. robertianum defatted with n-hexane was 
able to effectively decrease the production of NO by LPS-
stimulated Raw 264.7 macrophages, at a concentration of 100 
µg/mL [166]. The inability of the extract to modulate 5-
lipoxygenase (5-LOX) activity and inducible nitric oxide synthase 
(iNOS) expression at this concentration suggested that its anti-
inflammatory activity is based, at least partially, on its scavenging 
capacity against that radical. 
 Hernández-Guerrero et al. evaluated the anti-inflammatory 
activity of an aqueous extract of G. seemannii using the granuloma 
model in Wistar rats [167]. The extract at doses of 125, 250 and 500 
mg/Kg presented anti-inflammatory activity similar to that of in-
domethacin at 5 mg/Kg, without producing, however, any macro-
scopic damage of the gastroduodenal mucosa of the rats. 
 Recently Nam et al. studied the anti-inflammatory activity of a 
CH2Cl2 fraction from G. koreanum obtained by the partition of a 
crude 70% aqueous ethanol extract between water and hexane, 
CH2Cl2, EtOAc and n-BuOH, presumably in this order [168]. Co-
incubation of LPS-stimulated Raw 264.7 macrophage cells with the 
CH2Cl2 fraction (the most active one) at a concentration of 200 
µg/mL decreased NO production by 89% and also significantly 
decreased the expression of the pro-inflammatory mediator iNOS. 
Pre-treatment of reflux esophagitis (RE)-induced rats with the 
CH2Cl2 fraction at 200 µg/mL resulted in a reduction of oesophag-
eal mucosa damage to a condition similar to that of the normal con-
trol group. Moreover, at this concentration, the fraction improved 
oesophageal mucosa inflammation by inhibiting the expression of 
inflammatory proteins involved in nuclear factor κB (NF-κB) sig-
nalling pathways.  
4.11. Antinociceptive Activity 
 Li et al. investigated the peripheral and central antinociceptive 
activity of an aqueous extract of G. carolinianum by monitoring 
mice exposed to chemical and thermal stimuli, respectively [165]. 
The G. carolinianum extract considerably reduced writhing re-
flexes, in a dose-dependent way, in mice subjected to the acetic 
acid-induced writhing test. At the higher dose tested (500 mg/kg), 
the diminution of writhing responses after intra-peritoneal acetic 
acid injection was more substantial than that observed in the mice 
pre-treated with the positive control indomethacin (5 mg/kg), sug-
gesting that the extract possesses potent analgesic properties. The 
antinociceptive activity of the G. carolinianum extract was also 
demonstrated in the hot-plate test. Pre-treatment of mice with doses 
of 250 and 500 mg/kg of the extract significantly increased the 
latency period of mice when compared with the control group of 
animals, suggesting its central antinociceptive effect.  
 Küpeli et al. assessed the antinociceptive activity of an aqueous 
extract of G. finitimum, obtained by the partition of the crude 
MeOH extract between water and CHCl3, and several of its frac-
tions isolated by column chromatography in Swiss albino mice 
using the p-benzoquinone-induced abdominal constriction test [32]. 
At a dose of 100 mg/kg the aqueous extract and two flavonoid-rich 
fractions exhibited significant inhibition of writhing response in 
mice (21.3-32.0%) after intra-peritoneal injection of p-
benzoquinone, when compared to that promoted by acetylsalicylic 
acid (48.3%) at the same dose, without causing apparent acute tox-
icity or gastric damage. 
 G. bellum was the object of a rather extensive study in vivo 
concerning its antinociceptive activity in classical models of pain 
[162]. A 70% aqueous acetone extract of the plant showed antinoci-
ceptive peripheral activity in Wistar rats both upon systemic and 
local administration, significantly inhibiting formalin-induced noci-
ception. The inhibitory effect at a dose of 300 mg/kg and 800 
µg/paw was comparable to that of the positive controls indometha-
cin (30 mg/kg, 800 µg/paw) and diclofenac (30 mg/kg, 200 
µg/paw). In the acetic acid-induced writing test in CD1 albino mice 
the acetone-water extract at doses of 150 and 300 mg/kg showed 
significant inhibition of writhing frequency, in a dose-dependent 
manner, greater than that of indomethacin (10 mg/kg).  
4.12. Antiobesity Activity 
 In a study aiming at discovering new potential anti-obesity 
agents, Roh and Jung screened the crude EtOH extracts from four-
hundred plant species by monitoring the in vitro ability for the inhi-
bition of porcine pancreatic lipase (PPL) [169]. G. thunbergii, one 
of the four more promising extracts, exhibited 31.4% inhibition of 
PPL (at 100 µg/mL), against 42% of Orlistat, a well-known antili-
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pase agent used for long-term treatment of obesity. This extract also 
significantly reduced lipid accumulation in 3T3-L1 adipocytes, with 
relatively low toxicity to 3T3-L1 preadipocyte cells, further sug-
gesting anti-obesity activity. The treatment of high-fat diet-induced 
obese C57bl76J mice with a 70% aqueous EtOH extract of G. thun-
bergii considerably reduced body weight gain, adipose tissue accu-
mulation, adipocyte size and serum triglycerides, total cholesterol 
and low-density lipoprotein-cholesterol levels [170]. The levels of 
serum toxicological markers did not show meaningfully adverse 
toxic effects. The anti-obesity effects observed were mediated by 
altering the adipokine levels and downregulating the expression of 
transcription factors and lipogenic enzymes involved in lipid me-
tabolism. The anti-obesity, as well as the anti-hyperlipidemic ef-
fects of an n-BuOH soluble fraction from a MeOH extract of G. 
thunbergii, have also recently been observed in high-fat diet-
induced obese Sprague-Dawley rats [171]. 
4.13. Antioxidant Activity 
 The antioxidant capacity has been the most assessed bioactivity 
within the Geranium genus, encompassing about thirty studied 
species of diverse geographic origins (Table 5). A number of ana-
lytical methods have been used to evaluate the antioxidant capacity 
of different Geranium extracts. The majority of the assessments 
have been performed by the 2,2-diphenyl-1-picrylhydrazyl (DPPH) 
free radical scavenging assay, which is the most extensively used in 
vitro method for antioxidant activity evaluation due to its rapidity, 
simplicity and low cost in comparison with other methods [195]. 
Other electron transfer-based assays such as 2,2'-azinobis-(3-
ethylbenzothiazoline-6-sulfonic acid) (ABTS), ferric reducing anti-
oxidant power (FRAP) and reducing power have also been used in 
some extension. 
 Because each antioxidant assay has a different mechanism, 
redox potential, pH and solvent dependencies, etc. [196], there is 
no single method capable to provide unambiguous data about the 
total antioxidant capacity of a biological matrix. For that reason, it 
is considered that the best solution is to use simultaneously differ-
ent assays for the same sample [197], a procedure that was followed 
in many studies of the antioxidant activity of Geranium species. 
Although the results of antioxidant capacity obtained for the differ-
ent Geranium species and even for those obtained by different 
authors for the same single species are not comparable for the rea-
sons pointed out above, the general trend observed among the in-
vestigated extracts was a significant antioxidant capacity. In many 
cases, comparisons with well-known antioxidants, either natural or 
synthetic, have been made that substantiate it. 
 The antioxidant properties of plants are intimately related to 
the presence of phenolic compounds [198]. In many Geranium 
species, a reliable direct correlation between antioxidant activity 
and the total content of phenolic compounds has been observed 
[104, 177, 180, 185, 194, 199]. 
 Besides their role as scavengers of excessive injurious free 
radicals, there is recent evidence that polyphenolic compounds also 
have indirect antioxidant effects through induction of first-line de-
fence antioxidant endogenous enzymes such as are superoxide dis-
mutase (SOD), catalase (CAT), glutathione peroxidase (GP) and 
glutathione reductase (GR) [200]. Sabuncuoğlu and Şöhretoğlu 
investigated the effects of EtOAc, n-BuOH, MeOH and water ex-
tracts of G. tuberosum on the levels of glutathione (GSH), an im-
portant tripeptide of the non-enzymatic antioxidant defence system, 
and on the activities of the enzymes SOD and CAT from human 
erythrocytes in vitro [201]. All extracts prevented H2O2-induced 
decrease of GSH levels and increased CAT and SOD activities, in a 
dose-depend manner, the EtOAc extract being the most potent anti-
oxidant at 100 µg/mL, and possessing the highest polyphenol con-
tent (ca 450 µmol CE/g). However, apart from the MeOH extract at 
the concentration of 100 mg/mL, all other extracts did not improve 
resistance of human erythrocytes to H2O2-induced hemolysis. 
 In another study, a 70% aqueous EtOH extract of G. collinum 
roots increased SOD, CAT and GR activities, by factors ranging 
from 1.4 to 2.7, in erythrocytes from rats with alloxan-induced dia-
betes [202]. A significant decrease in erythrocyte membrane lipid 
peroxidation (LPO) was also observed. 
4.14. Antiprotozoal Activity 
 The antiprotozoal activity in the Geranium genus seems to have 
been assessed only in two species. In a screening of the antiproto-
zoal potential of some Mexican medicinal plants, Calzada et al. 
found that the MeOH extract of the roots of G. niveum possessed 
significant in vitro activity against axenically grown trophozoites of 
Entamoeba histolytica HM1:IMSS (IC50 = 8.7 µg/mL), the protozoa 
causing amoebic dysentery, and Giardia lamblia IMSS:0989:1 
(IC50 = 20.6 µg/mL), the microorganism responsible for giardiasis 
[47]. Metronidazole, an imidazolic antiprotozoal drug, was used as 
positive control presenting IC50 = 0.04 µg/mL for E. histolytica and 
IC50 = 0.21 µg/mL for G. lamblia. 
 G. mexicanum, an endemic species also used in Mexican tradi-
tional medicine, also possesses antiprotozoal properties. While the 
crude MeOH extract of the aerial parts of the plant presented weak 
in vitro activity against E. histolytica HM1:IMSS and G. lamblia 
IMSS:0989:1 (IC50 = 139.9 and 267.1 µg/mL, respectively) [203], 
the CH2Cl2-MeOH (1:1) extract of the roots was shown to be 
somewhat more active, with an IC50 value of 79.2 µg/mL for E. 
histolytica and 100.4 µg/mL for G. lamblia [36]. Suspension of the 
late crude dry extract in 9% aqueous MeOH and extraction with 
EtOAc furnished an EtOAc soluble fraction with improved antipro-
tozoal activity (E. histolytica IC50 = 66.7 µg/mL; G. lamblia IC50 = 
63.7 µg/mL). In both cases, besides metronidazole, emetine was 
used likewise as control displaying IC50 = 1.05 µg/mL for E. histo-
lytica and IC50 = 0.42 µg/mL for G. lamblia. The MeOH extract of 
the roots of G. mexicanum also exhibited activity against the flagel-
late protozoan Trichomonas vaginalis GT3, the etiological agent of 
trichomoniasis, with an IC50 value of 56.0 µg/mL [37]. 
4.15. Antipyretic Activity 
 Li et al. showed that an aqueous extract of G. carolinianum 
possessed significant antipyretic action, in a dose-dependent man-
ner, in Sprague-Dawley rats with fever induced by intra-peritoneal 
injection of lipopolysaccharides (LPS) [165]. At doses of 250 and 
500 mg/kg the extract displayed antipyretic effect similar to that of 
paracetamol at 100 mg/kg. 
 An aqueous extract of G. ocellatum leaves at a dose of 200 
mg/kg also exhibited antipyretic activity in Brewer’s yeast-induced 
pyrexia in rats, comparable to that of aspirin (100 mg/kg) [138]. 
4.16. Antiviral Activity  
 The antiviral potential of species from the Geranium genus has 
been assessed against influenza virus, herpes simplex virus type 1 
(HSV-1) and type 2 (HSV-2), hepatitis B virus (HBV) and human 
immunodeficiency virus (HIV). The investigation of the anti-
influenza activity of Geranium genus has been dominated by the 
studies conducted by Serkedjieva’s research group with G. san-
guineum. A MeOH extract of the plant, previously defatted with 
petroleum ether, which was termed polyphenolic complex, was 
found to be able to inhibit pronouncedly the reproduction of several 
strains of influenza A and B virus, both in vitro (CEF, MDCK and 
CAM cells) and in ovo (embryonated hen’s eggs) [204]. It was 
shown that the inhibitory effect was dose-dependent, strain-specific 
and dependent on the biological test medium. The extract also re-
duced the mortality of mice in experimental lethal influenza 
A/Aichi/2/68 (H3N2) virus infection and prolonged the survival 
time of the infected animals. The selectivity of the anti-influenza 
activity of the polyphenolic complex in vitro was further confirmed 
against several other strains of subtypes H1N1, H2N2, H3N2, 
H3N8, H7N1 and H7N7 of influenza A virus (cultivated in CEF 
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Table 5. Antioxidant activity and total phenolics content of Geranium species. 
Geranium Species Part Used Extract Method Antioxidant Activity Total Phenolics Content References 
G. ayavacence Whole plant H2O DPPH (IC50) 19 µg/mL - [172]  
- - - PNRSA (IC50) 21 µg/mL - - 
- - - PRSA (IC50) 14 µg/mL - - 
- - - HRSA (IC50) 105 µg/mL - - 
G. bellum Aerial parts EtOAc1 ABTS (% inhibition)2 ~ 953 - [173]  
- - MeOH1 ABTS (% inhibition)2 ~ 403 - - 
- - H2O1 ABTS (% inhibition)2 ~ 203 - - 
G. caeruleum Aerial parts MeOH/H2O (80/20) DPPH (IC50)4 ~ 30 µg/mL3 - [174]  
G. collinum Aerial parts EtOH/H2O (70/30) DPPH (IC50) 0.027 ± 0.002 mg/mL 131.7 ± 7.86 mg GAE/g [175]  
- - - ABTS (IC50) 0.15 ± 0.01 mg/mL - - 
- - - FRAP 1852.75 ± 77.4 mmol Fe2+/g - - 
- Roots EtOH/H2O (70/30) DPPH (IC50) 0.045 ± 0.003 mg/mL 82.60 ± 4.94 mg GAE/g - 
- - - ABTS (IC50) 0.19 ± 0.02 mg/mL - - 
- - - FRAP 1030.52 ± 58.9 mmol Fe2+/g - - 
- Roots H2O DPPH (IC50)5 15.17 ± 0.84 µg/mL 12.21 ± 0.10 mg GAE/g [152]  
- - EtOH/H2O (30/70) DPPH (IC50)5 10.89 ± 0.63 µg/mL 83.74 ± 0.18 mg GAE/g - 
- - EtOH/H2O (50/50) DPPH (IC50)5 11.21 ± 0.49 µg/mL 349.84 ± 0.21 mg GAE/g - 
- - EtOH/H2O (70/30) DPPH (IC50)5 12.69 ± 0.6 µg/mL 180.14 ± 0.11 mg GAE/g - 
- - EtOH DPPH (IC50)5 11.23 ± 0.7 µg/mL 100.42 ± 0.14 mg GAE/g - 
G. columbinum Aerial parts MeOH/H2O (80/20) DPPH (IC50)4 ~ 30 µg/mL3 - [174]  
G. favosum Whole plant CH2Cl26 DPPH (% inhibition)7 16.38 ± 0.00 0.254 ± 0.02 mg GAE/g [176]  
- - - FCC (% inhibition)8 30.99 ± 0.03 - - 
- - EtOAc6 DPPH (% inhibition)7 12.17 ± 0.01 0.223 ± 0.12 mg GAE/g - 
- - - FCC (% inhibition)8 13.13 ± 0.08 - - 
- - MeOH6 DPPH (% inhibition)7 92.06 ± 0.00 1.738 ± 0.05 mg GAE/g - 
- - - FCC (% inhibition)8 4.25 ± 0.08 - - 
- - - DMPD (% inhibition)9 55.73 ± 0.16 - - 
G. glaberrimum  Aerial parts EtOAc10 DPPH (% inhibition)11 ~ 903 - [99]  
- - n-BuOH10 DPPH (% inhibition)11 ~ 803 - - 
- - H2O10 DPPH (% inhibition)11 ~ 53 - - 
G. kikianum  Aerial parts essential oil12 DPPH (IC50)13 69.7 ± 0.5 mg/mL - [177]  
- - residual H2O12 DPPH (IC50)13 0.20 ± 0.03 mg/mL 100.2 ± 1.7 mg GAE/g - 
G. krameri Leaves EtOH/H2O (70/30) DPPH (IC50)16 8.72 µg/mL - [126]  
G. lasiopus  Aerial parts EtOAc10 DPPH (% inhibition)15 80.143 - [102]  
- - n-BuOH10 DPPH (% inhibition)15 66.167 - - 
- - H2O10 DPPH (% inhibition)15 2.447 - - 
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- Aerial parts EtOAc10 H2O2-ILP (% inhibition)16,17 ~ 703 - [178]  
- - n-BuOH10 H2O2-ILP (% inhibition)16,17 ~ 653 -  
- - H2O10 H2O2-ILP (% inhibition)16,17 ~ 703 -  
G. lucidum  Aerial parts MeOH/H2O (80/20) DPPH (IC50)4 ~ 45 µg/mL3 - [174]  
G. macrorrhizum Aerial parts MeOH/H2O (80/20) DPPH (IC50)4 10.58 µg/mL - [174]  
- Leaves EtOAc DPPH (% inhibition)18 26.9 ± 1.4 25.9 ± 0.2 mg mg GAE/g [179]  
- - Acetone DPPH (% inhibition)18 44.6 ± 1.2 -  
- - MeOH DPPH (% inhibition)18 91.7 ± 0.6 -  
- - - ABTS (% inhibition)18 ~ 100 -  
- Leaves MeOH DPPH 178.7 ± 1.8 mg TE/g 160.2 ± 3.1 mg GAE/g [104]  
- - - ABTS 323.3 ± 1.2 mg TE/g - - 
- - - IRA 84.2 ± 0.2 mg GAE/g - - 
- - - FRAP 1347.9 ± 46.7 µmol Fe2+/g - - 
- - - CUPRAC 466.0 ± 4.1 mg TE/g - - 
- - EtOH DPPH 71.0 ± 0.5 mg TE/g 109.5 ± 3.8 mg GAE/g - 
- - - ABTS 205.9 ± 1.0 mg TE/g - - 
- - - IRA 17.83 ± 0.3 mg GAE/g - - 
- - - FRAP 936.6 ± 26.3 µmol Fe2+/g - - 
- - - CUPRAC 355.0 ± 6.5 mg TE/g - - 
- - Acetone DPPH 9.50± 0.09 mg TE/g 13.8 ± 0.5 mg GAE/g - 
- - - ABTS 11.3 ± 0.09 mg TE/g - - 
- - - IRA 4.0 ± 0.3 mg GAE/g - - 
- - - FRAP 79.5 ± 3.7 µmol Fe2+/g - - 
- - - CUPRAC 30.5 ± 0.4 mg TE/g - - 
- - EtOAc DPPH 4.2 ± 0.09 mg TE/g 6.2 ± 0.4 mg GAE/g - 
- - - ABTS 5.7 ± 0.08 mg TE/g - - 
- - - IRA 2.1 ± 0.03 mg GAE/g - - 
- - - FRAP 30.4 ± 1.3 µmol Fe2+/g - - 
- - - CUPRAC 21.1 ± 0.3 mg TE/g - - 
- Rhizomes MeOH DPPH 106.4 ± 1.8 mg TE/g 85.7 ± 1.3 mg GAE/g - 
- - - ABTS 169. 5 ± 1.1 mg TE/g - - 
- - - IRA 42.4 ± 0.2 mg GAE/g - - 
- - - FRAP 632.1 ± 9.0 µmol Fe2+/g - - 
- - - CUPRAC 268.9 ± 2.2 mg TE/g - - 
- - EtOH DPPH 50.0 ± 0.5 mg TE/g 50.6 ± 2.0 mg GAE/g - 
- - - ABTS 72.2 ± 1.0 mg TE/g - - 
- - - IRA 11.6 ± 0.3 mg GAE/g - - 
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- - - FRAP 355.3 ± 4.0!"mol Fe2+/g! - - 
- - - CUPRAC 207.5 ± 3.2 mg TE/g - - 
- - Acetone DPPH 20.4 ± 0.7 mg TE/g 22.4 ± 0.8 mg GAE/g - 
- - - ABTS 20.3 ± 0.1 mg TE/g - - 
- - - IRA 8.5 ± 0.4 mg GAE/g - - 
- - - FRAP 108.3 ± 6.0!"mol Fe2+/g! - - 
- - - CUPRAC 49.8 ± 0.6 mg TE/g - - 
- - EtOAc DPPH 4.1 ± 0.2 mg TE/g 5.5 ± 0.06 mg GAE/g - 
- - - ABTS 4.4 ± 0.05 mg TE/g - - 
- - - IRA 2.1 ± 0.07 mg GAE/g - - 
- - - FRAP 24.6 ± 0.8!"mol Fe2+/g! - - 
- - - CUPRAC 14.8 ± 0.08 mg TE/g - - 
- Leaves subcritical H2O DPPH19 197.0 ± 4.3 mg TE/g ~ 140 mg GAE/g [105]  
- - - FRAP19 148.32 ± 10.75 mg AAE/g - - 
- - - TAC20 31.65 ± 1.22 mg GAE/g - - 
- Leaves MeOH DPPH (IC50)21 14.1!µg/mL! - [133]  
- - - ABTS (IC50)22 21.2 µg/mL! - - 
- - - FRAP23 2419.8!"M Fe2+/mg! - - 
- Roots MeOH DPPH (IC50)21 5.5 µg/mL! - - 
- - - ABTS (IC50)22 4.7 µg/mL! - - 
- - - FRAP23 3566.4!"M Fe2+/mg! - - 
- Flowers EtOH/H2O (95/5) DPPH 242.9 ± 0.1 mM TE/g 19.79 ± 0.11 mg GAE/g [180]  
- - - FRAP 106.3 ± 0.4 mM TE/g - - 
- - EtOH/H2O (70/30) DPPH 162.1 ± 0.4 mM TE/g 10.48 ± 0.03 mg GAE/g - 
- - - FRAP 97.7 ± 0.2 mM TE/g - - 
- - MeOH/H2O (80/20) DPPH 156.8 ± 0.3 mM TE/g 9.89 ± 0.05 mg GAE/g - 
- -- - FRAP 67.7 ± 0.2 mM TE/g - - 
- - H2O DPPH 192.4 ± 0.1 mM TE/g 12.35 ± 0.07 mg GAE/g - 
- - - FRAP 97.7 ± 0.5!mM TE/g! - - 
G. molle Whole plant H2O (infusion) DPPH (EC50)24 324 ± 9!µg/mL! 79 ± 1 mg GAE/g [128]  
- - - β-Carotene/linoleic acid (EC50)25 197 ± 8!µg/mL! - - 
- - - TBARS (EC50)26 54 ± 3!µg/mL! - - 
- - - Reducing power (EC50)27 141 ± 1!µg/mL! - - 
- - H2O (decoction) DPPH (EC50)24 248 ± 4!µg/mL! 63 ± 1 mg GAE/g - 
- - - β-Carotene/linoleic acid (EC50)25 249 ± 9!µg/mL! - - 
- - - TBARS (EC50)26 144 ± 7!µg/mL! - - 
- - - Reducing power (EC50)27 170 ± 6!µg/mL! - - 
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- - n-Hexane DPPH (EC50)24 1816 ± 126!µg/mL! 13 ± 1 mg GAE/g - 
- - - β-Carotene/linoleic acid (EC50)25 226 ± 4!µg/mL! - - 
- - - TBARS (EC50)26 98 ± 4!µg/mL! - - 
- - - Reducing power (EC50)27 266 ± 5 µg/mL! - - 
- - CH2Cl2 DPPH (EC50)24 #10 000!µg/mL! 6.15 ± 0.03 mg GAE/g - 
- - - β-Carotene/linoleic acid (EC50)25 253 ± 11!µg/mL! - - 
- - - TBARS (EC50)26 130 ± 6!µg/mL! - - 
- - - Reducing power (EC50)37 265 ± 1!µg/mL! - - 
- - EtOAc DPPH (EC50)24 128 ± 5!µg/mL! 216 ± 2 mg GAE/g - 
- - - β-Carotene/linoleic acid (EC50)25 212 ± 5!µg/mL! - - 
- - - TBARS (EC50)26 34 ± 2!µg/mL! - - 
- - - Reducing power (EC50)27 51 ± 1!µg/mL! - - 
- - Acetone DPPH (EC50)24 18.9 ± 0.5!µg/mL! 497 ± 8 mg GAE/g - 
- - - β-Carotene/linoleic acid (EC50)25 61 ± 3!µg/mL! - - 
- - - TBARS (EC50)26 6.5 ± 0.2!µg/mL! - - 
- - - Reducing power (EC50)27 20.3 ± 0.2!µg/mL! - - 
- - MeOH DPPH (EC50)24 135 ± 3!µg/mL! 76 ± 5 mg GAE/g - 
- - - β-Carotene/linoleic acid (EC50)25 274 ± 6!µg/mL! - - 
- - - TBARS (EC50)26 38 ± 2!µg/mL! - - 
- - - Reducing power (EC50)27 105 ± 4!µg/mL! - - 
G. nepalense Whole plant EtOH/H2O (70/30) DPPH (IC50) 46.3 ± 0.84!µg/mL! 169.4 ± 7.84 mg GAE/g [181]  
- - - ABTS (IC50) 80.9 ± 0.77!µg/mL! - - 
- - - SOD-like activity (IC50) 23.4 ± 1.25!µg/mL! - - 
G. niveum Roots MeOH/CHCl3 (1/1) DPPH (IC50)28 7.3 µg/mL - [48]  
- - - ABTS (IC50)29 17.8 µg/mL - - 
- - - SRSA (IC50)30 6.5 µg/mL" - - 
- - - HRSA (IC50)31 0.2 µg/mL - - 
  CHCl332 DPPH (IC50)31 92.0 µg/mL - - 
- - - HRSA (IC50)31 0.1 µg/mL - - 
G. pratense Leaves & flowers H2O DPPH (% control) 13 - [182]  
- - - SRSA (% control)" ~53 - - 
- - - HRSA (% control) 27 - - 
G. psilostemon Aerial parts EtOAc10 DPPH (% inhibition)11 ~ 803 - [99]  
- - n-BuOH10 DPPH (% inhibition)11 ~ 403 - - 
- - H2O10 DPPH (% inhibition)11 ~ 203 - - 
- Aerial parts EtOAc10 SRSA (IC50) 29.4!µ$/mL! 345.06. ±.0.12 mg GAE/g [131]  
- - - NORSA (IC50) 98.4!µ$/mL! - - 
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- - - ABTS33 0.371 ± 0.29!µM TE! - - 
- - n-BuOH10 SRSA (IC50) 29.4!µ$/mL! 281.08 ± 0.23 mg GAE/g - 
- - - NORSA (% inhibition)34 ~ 203 - - 
- - - ABTS33 0.301 ± 0.30!µM TE! - - 
- - H2O10 SRSA (% inhibition)35 ~ 603 224.64. ±.0.21 mg GAE/g - 
- - - NORSA (% inhibition)34 ~ 253 - - 
- - - ABTS33 0.284 ± 0.07µM TE! - - 
G. purpureum Leaves ground material PF36 3.1 28.2 ± 0.1 mg GAE/g [109]  
- - MeOH PF36 2.9 - - 
- Aerial parts H2O TAA 333.30 ± 15.0 mg AAE/g 219.52 ± 9.35 mg GAE/g [108]  
- - - Reducing power 169.07 ± 3.21 mg Trolox/g - - 
- - - FRAP 467.24 ± 7.85 mg Trolox/g - - 
- - - DPPH (IC50) 211.57 ± 5.82 µg/mL - - 
- - EtOH/H2O (80/20) TAA 472.04 ± 22.99 mg AAE/g 293.22 ± 14.28 mg GAE/g - 
- - - Reducing power 295.51 ± 9.53 mg Trolox/g - - 
- - - FRAP 705.91 ± 15.21 mg Trolox/g - - 
- - - DPPH (IC50) 211.44 ± 10.33 µg/mL - - 
- - EtOH TAA 536.90 ± 21.67 mg AAE/g 326.90 ± 7.82 mg GAE/g - 
- - - Reducing power 681.58 ± 20.18 mg Trolox/g - - 
- - - FRAP 783.48 ± 20.50 mg Trolox/g - - 
- - - DPPH (IC50) 197.16 ± 7.38 µg/mL - - 
- Aerial parts EtOH DPPH (IC50)37 1.700 ± 0.001 µg/mL 0.368 ± 0.002 mg GAE/mg [183]  
- - - ABTS (IC50)38 259.89 ± 0.02 mM TE/mg - - 
- - - FCC (%)39 31.67 ± 0.95 - - 
- Aerial parts EtOAc10 DPPH (% inhibition)15 88.761 - [102]  
- - n-BuOH10 DPPH (% inhibition)15 40.390 - - 
- - H2O10 DPPH (% inhibition)15 33.708 - - 
G. pyrenaicum Aerial parts MeOH/H2O (80/20) DPPH (IC50)4 13.61 µg/mL - [174]  
G. robertianum Whole plant H2O (infusion) DPPH (EC50)24 65 ± 1 µg/mL 228 ± mg GAE/g [127]  
- - - β-Carotene/linoleic acid (EC50)25 145 ± 8 µg/mL - - 
- - - TBARS (EC50)26 7.24 ± 0.05 µg/mL - - 
- - - Reducing power (EC50)27 52 ± 1 µg/mL - - 
- - H2O (decoction) DPPH (EC50)24 60 ± 1 µg/mL 212 ± 4 mg GAE/g - 
- - - β-Carotene/linoleic acid (EC50)25 117 ± 4 µg/mL - - 
- - - TBARS (EC50)26 7.3 ± 0.2 µg/mL - - 
- - - Reducing power (EC50)27 61 ± 3 µg/mL - - 
- - n-Hexane DPPH (EC50)24 877 ± 9 µg/mL 30.7 ± 0.5 mg GAE/g - 
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- - - β-Carotene/linoleic acid (EC50)25 178 ± 10 µg/mL - - 
- - - TBARS (EC50)26 24 ± 1 µg/mL - - 
- - - Reducing power (EC50)27 234 ± 1 µg/mL - - 
- - CH2Cl2 DPPH (EC50)24 1304 ± 71 µg/mL 3.8 ± 0.1 mg GAE/g - 
- - - β-Carotene/linoleic acid (EC50)25 420 ± 36 µg/mL - - 
- - - TBARS (EC50)26 262 ± 9 µg/mL - - 
- - - Reducing power (EC50)27 544 ± 6 µg/mL - - 
- - EtOAc DPPH (EC50)24 231 ± 3 µg/mL 176 ± 3 mg GAE/g - 
- - - β-Carotene/linoleic acid (EC50)25 447 ± 19 µg/mL - - 
- - - TBARS (EC50)26 37.2 ± 0.4 µg/mL - - 
- - - Reducing power (EC50)27 125 ± 1 µg/mL - - 
- - Acetone DPPH (EC50)24 54 ± 1 µg/mL 347 ± 4 mg GAE/g - 
- - - β-Carotene/linoleic acid (EC50)25 110 ± 1 µg/mL - - 
- - - TBARS (EC50)26 0.36 ± 0.04 µg/mL - - 
- - - Reducing power (EC50)27 40.4 ± 0.2 µg/mL - - 
- - MeOH DPPH (EC50)24 58 ± 1 µg/mL 268 ± 8 mg GAE/g - 
- - - β-Carotene/linoleic acid (EC50)25 119 ± 1 µg/mL - - 
- - - TBARS (EC50)26 11.0 ± 0.4 µg/mL - - 
- - - Reducing power (EC50)27 48 ± 1 µg/mL - - 
- Leaves MeOH/H2O (99/1) DPPH (IC50)40 64.56 µg/mL - [112]  
- Leaves H2O (decoction)41 DPPH (IC50)42 7.6 ± 0.6 µg/mL - [166]  
- - - ABTS (IC50)43 3.9 ± 0.6 µg/mL - - 
- - - HRSA (IC50)44 45.1 ± 2.4 µg/mL - - 
- - - FRAP (IC50)45 63.3 ± 5.4 µg/mL - - 
- - - TBARS (IC50)46 115.8 ± 16.1 µg/mL - - 
- - - ORAC 1.8 ± 0.1 µM TE/mg - - 
- - - NORSA (IC50)47 20.0 ± 0.9 µg/mL - - 
- Stems H2O (decoction) )41 DPPH (IC50)42 17.3 ± 0.3 µg/mL - - 
- - - ABTS (IC50)43 5.8 ± 0.5 µg/mL - - 
- - - HRSA (IC50)44 59.8 ± 8.4 µg/mL - - 
- - - FRAP (IC50)45 93.5 ± 5.5 µg/mL - - 
- - - TBARS (IC50)46 210.4 ± 38.6 µg/mL - - 
- - - ORAC 1.3 ± 0.0 µM TE/mg - - 
- - - NORSA (IC50)47 24.2 ± 8.0 µg/mL! - - 
G. ruizii Whole plant EtOH/H2O (96/4) DPPH (% inhibition)48 23.7 - [148]  
- Aerial parts EtOH/H2O (96/4) DPPH (IC50)49 24.21 ± 2.14!µg/mL 35 ± 3.5 mg GAE/g [134] 
- - - ABTS (IC50)50 32.45 ± 2.00 µg/mL - - 
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G. sanguineum Aerial roots MeOH51 DPPH (IC50)52 13.86 ± 0.84 µg/mL 34.60 % (w/w) [184]  
- - - SRSA (IC50)53 26.0 µg/mL - - 
- - - 
β-Carotene/linoleic acid (% inhibi-
tion)54 
88-89 - - 
- Aerial parts MeOH/H2O (80/20) DPPH (IC50)4 11.93 µg/mL - [174]  
G. sibiricum Whole plant H2O (decoction) DPPH (IC50)55 2.92!µg/mL! 169.46 mg GAE/g [185]  
- - - SRSA (IC50)56 6.34!µg/mL! - - 
- - - NORSA (IC50)57 6.11!µg/mL! - - 
- - - β-Carotene/linoleic acid (IC50)58 4.58!µg/mL! - - 
- - - XOD inhibition (IC50)59 266.14!µg/mL! - - 
- - - Reducing power60 6.17!µg/mL! - - 
- - - FRAP61 3.91 mmol Fe2+/g - - 
- - EtOH/H2O (50/50) DPPH (IC50)55 2.46!µg/mL! 218.39 mg GAE/g - 
- - - SRSA (IC50)56 5.18!µg/mL! - - 
- - - NORSA (IC50)57 4.58!µg/mL! - - 
- - - β-Carotene/linoleic acid (IC50)58 4.01!µg/mL! - - 
- - - XOD inhibition (IC50)59 342.27!µg/mL! - - 
- - - Reducing power60 5.79!µg/mL! - - 
- - - FRAP61 6.67 mmol Fe2+/g - - 
- - Petroleum ether62 DPPH (IC50)55 48.34!µg/mL! 130.78 mg GAE/g - 
- - - SRSA (IC50)56 91.66!µg/mL! - - 
- - - NORSA (IC50)57 58.43!µg/mL! - - 
- - - β-Carotene/linoleic acid (IC50)58 70.16!µg/mL! - - 
- - - XOD inhibition (IC50)59 > 500 µg/mL! - - 
- - - Reducing power60 66.20!µg/mL! - - 
- - - FRAP61 1.29 mmol Fe2+/g - - 
- - EtOAc62 DPPH (IC50)55 0.93!µg/mL! 425.36 mg GAE/g - 
- - - SRSA (IC50)56 3.32!µg/mL! - - 
- - - NORSA (IC50)57 2.06!µg/mL - - 
- - - β-Carotene/linoleic acid (IC50)58 2.66!µg/mL! - - 
- - - XOD inhibition (IC50)59 198.85 µg/mL! - - 
- - - Reducing power60 1.64!µg/mL! - - 
- - - FRAP61 17.76!%%&'!()*+,$! - - 
- - n-BuOH62 DPPH (IC50)55 1.37!µg/mL! 327.17 mg GAE/g - 
- - - SRSA (IC50)56 3.35!µg/mL! - - 
- - - NORSA (IC50)57 2.75!µg/mL! - - 
- - - β-Carotene/linoleic acid (IC50)58 7.02!µg/mL! - - 
- - - XOD inhibition (IC50)59 314.02 µg/mL! - - 
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- - - Reducing power60 2.14!µg/mL! - - 
- - - FRAP61 13.22 mmol Fe2+/g - - 
- - H2O62 DPPH (IC50)55 18.33!µg/mL! 68.03 mg GAE/g - 
- - - SRSA (IC50)56 29.71!µg/mL! - - 
- - - NORSA (IC50)57 24.32!µg/mL! - - 
- - - β-Carotene/linoleic acid (IC50)58 39.87!µg/mL! - - 
- - - XOD inhibition (IC50)59 321.39 µg/mL! - - 
- - - Reducing power60 25.59!µg/mL! - - 
- - - FRAP61 2.5 mmol Fe2+/g - - 
- Whole plant H2O63 FRAP 2.61 mmol Fe2+/g - [186]  
- - - DPPH (IC50) 0.118 mg/mL - - 
- Whole plant MeOH DPPH (% inhibition) 92.9 ± 0.3 124.2 ±!-./!µg GAE/mL [114]  
G. tuberosum Aerial parts EtOAc10 DPPH (% inhibition)11 ~ 903 - [99]  
- - n-BuOH10 DPPH (% inhibition)11 ~ 753 - - 
- - H2O10 DPPH (% inhibition)11 ~ 353 - - 
- Aerial parts EtOAc64 H2O2-ILP (% of inhibition)16 ~ 803 - [187]  
- - n-BuOH64 H2O2-ILP (% of inhibition)16 ~ 653 - - 
- - H2O64 H2O2-ILP (% of inhibition)16 ~ 603 - - 
- Aerial parts EtOAc10 SRSA (% inhibition)35 ~ 703 389.09 ± 0.84 mg GAE/g [131]  
- - - NORSA (% inhibition)34 ~ 253 - - 
- - - ABTS33 0.326 ± 0.28!µM TE! - - 
- - n-BuOH10 SRSA (% inhibition)35 ~ 653 271.86 ± 0.42 mg GAE/g - 
- - - NORSA (% inhibition)34 ~ 203 - - 
- - - ABTS33 0.300 ± 0.21!µM TE! - - 
- - H2O10 SRSA (% inhibition)35 ~ 603 208.10 ± 0.82 mg GAE/g - 
- - - NORSA (% inhibition)34 ~ 203 - - 
- - - ABTS33 0.262 ± 0.34!µM TE! - - 
G. sylvicatum Aerial parts MeOH/H2O (80/20) DPPH (IC50)4 ~ 30!µg/mL3! - [174]  
G. thunbergii Stem, leaves  MeOH IAC water-soluble substances 598.7 ± 10.9!µmol AA/g! 53.3 ± 2.8 mg GAE/g [188]  
- - - IAC lipid-soluble substances 296.3 ± 26.8 µmol Trolox/g! - - 
- Stem, leaves EtOH/H2O (40/60) IAC water-soluble substances  9.76 ± 0.14 mmol AAE/g 104 ± 2.4 mg GAE/g [189]  
- - - IAC lipid-soluble substances  5.20 ± 0.04 mmol TE/g - - 
- Whole plant n-hexane65 DPPH (% inhibition)66 13.43 ± 0.67 83.72 ± 5.04 mg GAE/g [116]  
- - - ABTS (% inhibition)67 6.63 ± 0.33 - - 
- - CHCl365 DPPH (% inhibition)66 26.24 ± 1.01 148.83 ± 1.40 mg GAE/g - 
- - - ABTS (% inhibition)67 21.36 ± 1.90 - - 
- - AcOEt65 DPPH (% inhibition)66 80.88 ± 1.34 604.28 ± 1.95 mg GAE/g - 
- - - ABTS (% inhibition)67 80.12 ± 2.41 - - 
 
(Table 5) Contd.... 
 
1856    Current Pharmaceutical Design, 2020, Vol. 26, No. 16 Graça et al. 
Geranium Species Part Used Extract Method Antioxidant Activity Total Phenolics Content References 
- - n-BuOH65 DPPH (% inhibition)66 73.48 ± 1.15 465.65 ± 4.88 mg GAE/g - 
- - - ABTS (% inhibition)67 70.72 ± 1.28 - - 
- - H2O65 DPPH (% inhibition)66 13.76 ± 3.80 98.52 ± 1.18 mg GAE/g - 
- - - ABTS (% inhibition)67 15.54 ± 6.58 - - 
- Whole plant EtOH/H2O (95/5) DPPH (% inhibition)68 97.56 96.51 mg TAE/g [115]  
- - - NORSA (% inhibition)68 59.74 - - 
- Whole plant H2O (decoction) DPPH (% inhibition)69 100 - [190]  
- Whole plant MeOH/H2O (95/5) DPPH (% inhibition)70 98.33 - [191]  
- - - DCFH-DA (IC50)71 43.22!µg/mL - - 
G. tuberosum  Aerial parts MeOH/H2O (80/20) H2O2-ILP (% of inhibition)17,72 ~ 503 - [192]  
- - EtOAc10 H2O2-ILP (% of inhibition)17,72 ~ 753 - - 
- - n-BuOH10 H2O2-ILP (% of inhibition)17,72 ~ 653 - - 
- - H2O10 H2O2-ILP (% of inhibition)17,72 ~ 653 - - 
- Aerial parts EtOAc10 DPPH (% inhibition)15 92.821 - [102]  
- - n-BuOH10 DPPH (% inhibition)15 74.040 - - 
- - H2O10 DPPH (% inhibition)15 28.407 - - 
G. wallichianum Roots EtOAc73 DPPH (IC50)74 19.05 ± 0.90 µg/mL! - [193]  
- - n-BuOH73 DPPH (IC50)74 24.133 ± 0.56 µg/mL! - - 
- - H2O73 DPPH (IC50)74 25.35 ± 1.20 µg/mL! - - 
G. wilfordii Whole plant MeOH/H2O (80/20) FRAP  347.33 ± 7.99 µmol Fe2+/g 14.98 ± 0.64 mg GAE/g [194]  
- - - ABTS 215.98 ± 4.10 µmol TE/g! - - 
AA - Ascorbic acid. AAE- Ascorbic acid equivalent. ABTS - 2,2'-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid). BHA - 3-tert-Butyl-4-hydroxyanisole. BHT - 2,6-Di-tert-butyl-
4-methylphenol. CUPRAC - Cupric reducing antioxidant capacity. DCFH-DA - Dichlorodihydrofluorescein diacetate. DMPD - N,N-Dimethyl-p-phenylenediamine. DPPH - 2,2-
Diphenyl-1-picrylhydrazyl. EC50 - Extract concentration corresponding to 50% of antioxidant activity or 0.5 of absorbance in reducing power assay. FCC - Ferrous chelating capacity. 
FRAP - Ferric reducing antioxidant power. GAE - Gallic acid equivalent. H2O2-ILP hydrogen peroxyde-induced lipid peroxidation. HRSA - Hydroxyl radical scavenging activity. 
IAC - Integral antioxidant capacity. IC50 - Concentration at which inhibition is 50%. IRA - Iron (III) reduction activity. NORSA - Nitric oxide radical scavenging activity. ORAC - 
Oxygen radical absorbance capacity. PF - Protection factor. PNRSA - Peroxynitrite radical scavenging activity. PRSA - Peroxyl radical scavenging activity. SOD - Superoxide dismu-
tase. SRSA - Superoxide radical scavenging activity. TAC - Total antioxidant capacity. TAE - Tannic acid equivalent. TBARS - Thiobarbituric acid reactive substances. TE - Trolox 
(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) equivalent. XOD - Xanthine oxidase. 
1 Obtained, after defatting with n-hexane, by successive extraction with EtOAc, MeOH and H2O. 2 Concentration of the extract: 1.5 mg/mL. AA (100% inhibition) was used as refer-
ence compound. 3 Estimated from bar chart. 4 Quercetin (IC50 = 3.1 µg/mL) was used as a reference compound. 5 AA (IC50 = 5.34 ± 0.42 µg/mL) was used as reference compound. 6 
Obtained, after defatting with n-hexane, by successive extraction with CH2Cl2, EtOAc and MeOH. 7 Quercetin (90.13 ± 0.31 % inhibition) was used as a reference compound. 8 Quer-
cetin (61.87 ± 0.98 % inhibition) was used as reference compound. 9 Quercetin (68.32 ± 0.99% inhibition) was used as a reference compound. 10 Obtained by successive partition of a 
crude MeOH/H2O (80/20) extract between H2O and petroleum ether, EtOAc and n-BuOH. 11 Concentration of the extract: 50 µg/mL. AA (0!60% inhibition, estimated from bar chart) 
was used as reference compound. 12 Obtained by hydrodistillation. 13 BHT (IC50 = 0.21 ± 0.01 mg/mL) and thymol (1.9 ± 0.04 mg/mL) were used as reference compounds. 14 AA (IC50 
= 5.65 µg/mL) was used as reference compound. 15 Concentration of the extract: 50 µg/mL. AA (57.623 % inhibition) was used as reference compound. 16 Concentration of the ex-
tract: 50 µg/mL. AA (0"60 % inhibition, estimated from bar chart) and Trolox (0!40% inhibition, estimated from bar chart) were used as reference compounds. 17 In human red blood 
cells. 18 Concentration of the extract: 2.5 mg/mL. 19 Extraction at 160ºC. 20 Extraction at 130ºC. 21 Caffeic acid (IC50 = 1.7 µg/mL) was used as reference compound. 22 Caffeic acid 
(IC50 = 2.0 µg/mL) was used as a reference compound. 23 Caffeic acid (3383.5 "1! ()*+,%$) was used as reference compound. 24 Trolox (EC50 = 42 µg/mL) was used as reference 
compound. 25 Trolox (EC50 = 18 µg/mL) was used as a reference compound. 26 Trolox (EC50 = 23 µg/mL) was used as reference compound. 27 Trolox (EC50 = 41 µg/mL) was used as 
reference compound. 28 AA (IC50 = 54.6 µM) and resveratrol (IC50 = 323.9 µM) were used as reference compounds. 29 AA (IC50 = 57.0 µM) and resveratrol (IC50 = 5.8 µM) were used 
as reference compounds. 30 AA (IC50 > 1000 µM) and resveratrol (IC50 > 1000 µM) were used as reference compounds. 31 Resveratrol (IC50 = 0.4 µM) was used as reference com-
pounds. 32 Obtained by partition of the crude MeOH/CHCl3 (1/1) extract with CHCl3 and H2O. 33 Concentration of the extract: 50 µg/mL. 34 Concentration of the extract: 50 µg/mL. 
Quercetin (0!60% inhibition, estimated from bar chart) was used as reference compound. 35 Concentration of the extract: 50 µg/mL. Quercetin (0!75% inhibition, estimated from bar 
chart) was used as reference compound. 36 Determined by the Rancimat test using sunflower oil as substrate. 37 AA (IC50 = 3.000 ± 0.004 µg/mL) and BHT (IC50 = 9.000 ± 0.003 
µg/mL) were used as reference compound. 38 BHT (IC50 = 252.02 ± 0.04) was used as reference compound. 39 Concentration of the extract: 50 µg/mL. EDTA (95.78 ± 0.20) was used 
as reference compound. 40 Trolox (IC50 = 2.08 µg/mL) was used as reference compound. 41 Defatted with n-hexane. 42 AA (IC50 = 4.8 ± 0.3 µg/mL)"was used as reference compound. 
43 AA (IC50 = 1.3 ± 0.2 µg/mL) was used as a reference compound. 44 Mannitol (IC50 = 196.2 ± 16.4 µg/mL) was used as reference compound. 45 BHT (IC50 = 20.0 ± 0.2 µg/mL) was 
used as reference compound. 46 Trolox (IC50 = 41.1 ± 5.2 µg/mL) was used as reference compound. 47 AA (IC50 = 285.7 ± 15.4 µg/mL) was used as reference compound. 48 Concen-
tration of the extract: 1 µg/mL. ΑΑ (~ 30 % inhibition, estimated from bar chart) and Trolox (~70% inhibition, estimated from bar chart) were used as reference compounds. 49 AA 
(IC50 = 4.01 ± 1.26 µg/mL) was used as reference compound. 50 AA (IC50 = 5.00 ± 0.80 µg/mL) was used as a reference compound. 51 After defatting with petroleum ether. 52 BHT 
(IC50 = 19.81 ± 0.05 µg/mL) was used as reference compound. 53 SOD from bovine erytrocytes (IC50 = 1.04 µg/mL) and caffeic acid (IC50 = 4.9 µg/mL) were used as reference com-
pounds. 54 BHT (~ 90% of inhibition, estimated from bar chart) was used as reference compound. 55 AA (IC50 = 9.5 µg/mL) was used as reference compound. 56 Trolox (IC50 = 21.54 
µg/mL) was used as reference compound. 57 AA (IC50 = 1.03 µg/mL) was used as reference compound. 58 BHT (IC50 = 10.47 µg/mL) was used as a reference compound. 59 Allopuri-
nol (IC50 = 1.72 µg/mL) was used as reference compound. 60 Extract concentration corresponding to 0.5 of absorbance. Trolox (IC50 = 0.96 µg/mL) was used as a reference com-
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pound. 61 AA (IC50 = 11.38 %%&'! ()*+,$) was used as reference compound. 62 Obtained by successive partition of a crude EtOH/H2O (50/50) extract between H2O and petroleum 
ether, EtOAc and n-BuOH. 63 Microwave assisted enzymatic (cellulase) extraction. 64 Obtained from the partition of a crude MeOH extract between H2O and petroleum ether, EtOAc 
and n-BuOH. 65 Obtained by successive partition of a MeOH/H2O (95/5) extract between H2O and n-hexane, CHCl3, EtOAc and n-BuOH. 66 Concentration of the extract: 50 µg/mL. 
BHA (27.02 ± 3.57% inhibition)!and AA (96.52!± 0.29% inhibition) were used reference compounds. 67 Concentration of the extract: 50 µg/mL. BHA (87.70 ± 2.94% inhibition) and 
AA (99.05 ± 0.92% inhibition) were used as reference compounds. 68 Concentration of the extract: 1%. 69 Concentration of the extract: 0.77 mg/mL. α-Tocopherol, AA and cysteine 
(100% inhibition at 58.8, 68.8 and 128.6 µM, respectively) were used as reference compounds. 70 Concentration of the extract: 50 µg/mL. Quercetin (78.05% inhibition) was used as 
reference compound. 71 Using human keratinocytes (HaCaT). Quercetin (IC50 = 102.35 µg/mL) was used as a reference compound. 72 Concentration of the extract: 50 µg/mL. AA (0"
45% inhibition, estimated from bar chart) and Trolox (0!60% inhibition, estimated from bar chart) were used as reference compounds.73 Obtained by successive partition of a crude 
MeOH extract between H2O and n-hexane, CHCl3, EtOAc and n-BuOH. 74 BHA (IC50 = 8.0725 ± 0.65µg/mL) was used as a reference compound. 
 
and MDCK cells) [205, 206]. At non-toxic concentrations, the 
polyphenolic complex reduced the expression of hemagglutinin 
(HA) on the surface of CEF cells infected with A/chicken/ 
Rostock/34 (H7N1), virus-induced cytopathic effect (CPE), infec-
tious virus yield and plaque formation [206]. The results suggested 
that the early synthetic stages of replication were the most sensitive 
to the inhibitory action of the extract. Virus-specific protein synthe-
sis was also selectively inhibited. The polyphenolic complex was 
found to stimulate the phagocytic activity of peritoneal macro-
phages and blood polymorphonuclear leucocytes isolated from ICR 
mice and showed a beneficial effect on spontaneous nitric oxide 
production by the peritoneal and alveolar macrophages [207]. In 
comparison with the normal parent virus, the G. sanguineum poly-
phenol-rich extract affected in lesser extension the expression of 
HA, neuraminidase (NA) and nucleoprotein (NP), virus-induced 
CPE, plaque formation and infectious virus yield of two variants of 
the avian influenza virus A/chicken/Germany/34 (H7N1) with re-
duced sensitivity to the extract cultivated in CEF cells [208]. The 
polyphenolic complex was shown to protect ICR mice from mortal-
ity in experimental influenza A/Aichi/2/68 (H3N2) virus infection 
alternatively through enhancement and restoration of the host im-
mune response [209], regulation of the host lung protease activities 
[210] and exhibition of in vivo antioxidant and radical scavenging 
properties [211, 212]. A combined antiviral effect of the G. san-
guineum polyphenolic complex and ε-aminocaproic acid, a protease 
inhibitor, was observed in MDCK cells and mice infected with 
influenza A/Aichi/2/68 (H3N2) virus [213]. Combinations of the 
polyphenolic complex and ε-aminocaproic acid in particular con-
centrations resulted in the synergistic inhibition of virus replication 
in the MDCK cells and the protection of mice against viral infection 
as determined by infectious parameters including lung virus titers, 
lung weight, mean survival time and mortality rates. The combined 
dosage of the polyphenolic complex and ε-aminocaproic acid to the 
infected mice was shown to revert the levels of lung protease and 
protease-inhibitory activity, which were increased due to the infec-
tion, back to normal. Serkedjieva et al. also investigated the com-
bined protective effect of the G. sanguineum polyphenolic complex 
and a glycosylated Cu/Zn-containing superoxide dismutase pro-
duced by the fungus Humicula lutea 103 in experimental influenza 
A/Aichi/2/68 (H3N2) virus infection in ICR mice [214]. The result 
was a synergistically increased protection demonstrated by the sig-
nificant reduction of infectious parameters, such as lung consolida-
tion, lung virus titers, lung weights and mortality rates of infected 
animals, and the increase of survival times. Moreover, the levels of 
reactive oxygen species produced by alveolar macrophages as well 
as the levels of the lung antioxidant enzymes superoxide dismutase 
and catalase decreased to normal. A synergistic enhancement of the 
therapeutic efficacy in influenza A/Aichi/2/68 (H3N2) virus infec-
tion was also observed with the combined administration of the 
polyphenolic complex and vitamin C. The combined administration 
of the polyphenolic complex and rimantadine hydrochloride to 
human influenza virus A/Aichi/2/68 (H3N2)-infected MDCK cells 
was shown to reduce the risk of emergence of drug-resistant mu-
tants [215]. The same effect was observed in the experimental in-
fluenza A/Aichi/2/68 (H3N2) virus infection in mice. Sokmen et al. 
reported that the G. sanguineum polyphenolic complex, as well as 
its n-BuOH soluble fraction, significantly reduced the virus-induced 
CPE and the production of HA in MDCK cells infected with influ-
enza A/Aichi/2/68 (H3N2) virus [184]. In a murine model of ex-
perimental influenza infection with the same variant, the protection 
of the n-BuOH fraction was not relevant, while the EtOAc soluble 
fraction of the polyphenolic complex exhibited a significant protec-
tive effect in vivo, close to that of the whole extract. The aerosol 
administration of the polyphenolic complex proved to be very ef-
fective in experimental influenza A/Aichi/2/68 (H3N2) virus infec-
tion in ICR mice [216], reducing lung infectious virus titers and 
lung consolidation of the treated animals in comparison with the 
control. 
 The inhibitory effect of the polyphenolic complex obtained 
from G. sanguineum was also evaluated against HSV-1 reproduc-
tion in vitro (McIntyre and Kupka strains propagated in CEF and 
Vero cells) [204]. The extract was shown to display virucidal action 
against HSV-1 and reduced virus titer.  
 Serkedjieva and Ivancheva further explored the antiherpetic 
activity of G. sanguineum and studied the action of different polar 
extracts against HSV-1 (Kupka and KOS strains propagated in Vero 
and E6SM cells, respectively) and HSV-2 (G strain propagated in 
E6SM cells) [75]. The H2O soluble fraction of a MeOH extract of 
the defatted (petroleum ether) aerial roots of the plant was the least 
toxic for the cell cultures and inhibited significantly the replication 
of both HSV-1 and HSV-2, with EC50 values from 3.6 to 6.2 
µg/mL. The inhibitory effect was shown to be dose-dependent, 
strain-specific and to depend on the inoculum. It was observed that 
for the full expression of the antiviral effect, it was necessary the 
presence of the extract during the complete replicative cycle of the 
virus. In a preliminary assay in vivo the extract also delayed the 
development of herpetic vesicles in albino guinea pigs following 
infection with HSV-1 (Kupka strain) [75]. 
 A polyphenol-rich extract from G. carolinianum, obtained by 
extraction of the aerial parts of the plant with 50% aqueous EtOH, 
followed by partition between CHCl3 and H2O and purification of 
the aqueous phase by macroporous resin D101 adsorption (elution 
with 50% aqueous EtOH), showed significant anti-HBV activity 
both in vitro and in vivo [18]. The extract effectively inhibited the 
expression of hepatitis B virus surface antigen (HBsAg) and hepati-
tis B e antigen (HBeAg) in human HVB-transfected HepG2 2.2.15 
cells, in a dose-dependent manner, with IC50 values of 46.85 µg/mL 
and 65.60 µg/mL, respectively. The antiviral effect was additionally 
confirmed by the decrease of the levels of HBV DNA in the HepG2 
2.2.15 cells. In ducks infected with duck hepatitis B virus (DHBV) 
the polyphenolic extract, dosed intragastricly once a day for 10 
days, reduced plasma and liver DHBV DNA levels, in a dose-
dependent manner. Additionally, significant improvement of the 
ducks' livers was verified by histopathological analysis. Several 
organic fractions from a 95% aqueous EtOH extract of the aerial 
parts of G. carolinianum, obtained by sequential extraction of an 
aqueous solution of the crude ethanolic extract of the plant with 
different solvents (petroleum ether, CHCl3, EtOAc, n-BuOH), also 
shown activity against HBV [217]. The extracts inhibited the ex-
pression of HBsAg and HBeAg in HepG2 2.2.15 cells with inhibi-
tion ratios from 29.0 to 75.8%, and from 18.6 to 56.0%, respec-
tively. The EtOAc extract exhibited the highest anti-HBV activity 
and was also less toxic to cells. 
 The polyphenolic complex from G. sanguineum, which was 
extensively used in the studies against the influenza virus, was addi-
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tionally shown to have an inhibitory effect on the reproduction of 
HBV in vitro [218]. 
 In an in vitro screening of the inhibition ability of aqueous 
MeOH extracts of 70 plants against human immunodeficiency vi-
rus-1 reverse transcriptase, a key enzyme in the life cycle of the 
HIV-1, Mlinaric et al. found that the extract from G. phaeum was 
the second most potent, with an IC50 value of 0.067 mg/mL, after 
removal of tannins, which are regarded as non-specific enzyme 
inhibitors [219].  
 Earlier, Serkedjieva reported that the polyphenolic complex 
from G. sanguineum also inhibited the reproduction of HIV-1 in 
vitro [218]. 
4.17. Diuretic Activity 
 Although several species of the Geranium genus have been 
mentioned as diuretics, only G. seemannii seems to have been in-
vestigated regarding the ability to induce diuresis. Montejano-
Rodríguez et al. showed that the administration by gavage of a 
defatted EtOH extract of the plant to Wistar rats significantly in-
creased the urine output and electrolyte (sodium, potassium, and 
chloride) excretion, in a dose-dependent way, when compared to 
the control group [220]. The analogous action pattern between the 
EtOH extract and intraperitoneally administered furosemide, a 
standard diuretic drug, was considered suggestive of a similar 
mechanism of action. 
4.18. Other Enzyme Inhibitory Activities 
 Sigurdsson and Gudbjarnason showed that a 45% aqueous 
EtOH extract from G. sylvaticum was capable of inhibiting 
acetylcholinesterase in vitro, an enzyme that has been the main 
target for the symptomatic treatment of Alzheimer’s disease, with 
an IC50 = 3.56 mg/mL [221]. 
 An EtOAc soluble fraction from a 95% aqueous EtOH extract 
of G. thunbergii was shown to exhibit potent in vitro inhibitory 
activity against β-secretase enzyme BACE1, in a concentration-
dependent manner (69.39% at 50 µg/mL and 95.41% at 100 
µg/mL) [222]. BACE1 is a promising therapeutic target for ‘dis-
ease-modifying’ approaches to the treatment of Alzheimer’s disease 
by modulation of the deposition of extracellular amyloid β plaques 
[223].  
 One of the consequences of diabetes, as well as of galacto-
semia, is the development of cataracts through the polyol pathway 
in which the enzyme aldose reductase plays a central role [224]. 
Choi et al. found that the EtOAc soluble fraction of an EtOH ex-
tract of G. thunbergii inhibited rat lens aldose reductase activity 
with an IC50 = 2.64 µg/mL [225].  
 Ismail et al. observed that, contrary to the leaves of G. wallichi-
anum, which were devoid of inhibitory activity, the extracts of rhi-
zomes possessed varied activities against lipoxygenase and Jack 
Bean and Bacillus pasteurii ureases [117]. Lipoxygenases are di-
oxygenases enzymes that have been linked to the pathogenesis of 
various diseases, such as asthma and cancer [226]. Urease activity 
in human cells is implicated in the pathogenesis of clinical condi-
tions such as peptic ulcers and gastric cancer [227]. The AcOEt 
fraction, obtained from an initial MeOH extract partitioned succes-
sively between water and different organic solvents of increasing 
polarity, showed the highest inhibitory activities against lipoxy-
genase (47.5%) and Jack Bean and B. pasteurii ureases (83 and 
86%, respectively), considerably superior to those of the crude 
MeOH extract.  
 An EtOH extract of G. purpureum also revealed moderate anti-
urease activity with 29.43% inhibition at a concentration of 12.5 
mg/mL [183]. Thiourea, used as a positive control, exhibited 
78.24% of inhibition at the same concentration. 
 
4.19. Less Explored Activities 
 Recently, Boisvert et al. showed that a MeOH extract of G. 
sibiricum had a significant hair growth-promoting effect in vitro, by 
enhancing proliferation and migration of human dermal papilla 
cells (hDPCs), a primary cell type that regulates hair growth, supe-
rior to that of minoxidil [228]. In vivo, topical application of the G. 
sibiricum extract on shaved C57BL/6 mice for 3 weeks also shown 
to result in more significant hair growth than that obtained with 
minoxidil. 
 Starting from the observation that few plants can grow in the 
vicinity of G. carolinianum and G. koreanum plants, Qiu et al. in-
vestigated the allelopathic properties of their essential oils, obtained 
by hydrodistillation, against several weed species [229]. The essen-
tial oils were found to cause significant phytotoxicity on two impor-
tant agricultural weeds: Amaranthus viridis and Portulaca oleracea. 
CONCLUSION 
 The Geranium genus encompasses a number of species which 
are endowed with scientifically documented beneficial biological 
activities. Based on the studies undertaken to assess the correspond-
ing biological activities, many species seem to possess evident 
therapeutic potential for a variety of diseases. Notwithstanding the 
different biological activities that have been addressed in some 
extension, to date their assessment appears to has been performed 
only in vitro and in small animal models. Despite some herbal 
medicines are efficacious, there is unquestionably a need for more 
reliable information regarding their efficacy and safety and the 
ultimate proof can only be achieved by some form of rigorous clini-
cal research and standardization. 
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